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The growth and development of ovarian follicles is controlled primarily by
FSH and LH secreted by the anterior pituitary. In the ewe, the secretion of FSH and
LH by the pituitary is regulated by a number of ovarian factors, including oestradiol,
progesterone, and the glycoprotein dimers inhibin and activin. Two forms of inhibin
have been identified to date, inhibin A and inhibin B, with both consisting of a
common a-subunit and differing p-subunits. Although well researched in a number of
species, the levels of inhibins in the circulation and the expression of their subunits in
the gonads have yet to be examined as thoroughly in the sheep, a species in which the
ovulatory quota is rigorously controlled.
In order to identify the source of inhibin A in the ewe, ovaries were removed
at each of three points during the oestrous cycle (mid-luteal, early follicular and late
follicular), all visible antral follicles dissected out and hormone release measured
during incubation and in their follicular fluids. Large oestrogenic follicles were found
to be the main source of inhibin A in the ewe with large non-oestrogenic follicles also
releasing significant amounts of the hormone. The levels of inhibin A released by both
small antral follicles and large oestrogenic follicles during the early follicular phase
were significantly reduced compared to the luteal phase, possibly reflecting the fall in
FSH concentration at this time.
Conventional immunocytochemistry and dual label confocal microscopy were
used to investigate the expression of inhibin a, PA and PB subunit proteins in
different compartments of the ovarian follicle. All three subunits were found in the
granulosa cells of antral follicles with little variation in the relative amounts of the
proteins in follicles during the oestrous cycle. In addition, there was significant
immunostaining for both P-subunits (but not a subunit) in theca cells, with mRNA
expression of all three subunits confined to the granulosa cells. These findings are
compatible with the hypothesis that pA and PB activins diffuse from the granulosa
layer through the theca and possibly the adjacent stroma, where they may exert a
paracrine influence.
Significant amounts of inhibin B have not been detected in the blood or
follicular fluid of sheep using a specific two-site ELISA assay. The nature of
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inhibin/activin proteins present in ovarian cells and follicular fluid was therefore
investigated using Western blotting. A small amount of high molecular weight protein
(consistent with inhibin B precursor) was detected in protein extracts of ovarian cells.
Conversely, there were no inhibin B proteins present in follicular fluid, which
contained large quantities of inhibin A forms. Therefore, although all three inhibin
subunit mRNAs and proteins are expressed in the granulosa cells of antral follicles, it
seems unlikely that inhibin B is secreted outside the cell.
In order to explore further the forms of inhibin produced by the sheep,
subunit expression in the male was investigated. In most species studied (e.g. human,
rat), the male secretes exclusively inhibin B. In this work, both a and [IB subunit
proteins were found in the seminiferous tubules of rat testes. In contrast, all three
subunit proteins were present in the testis of the ram, which like the ewe, apparently
only secretes inhibin A. Together, these findings are consistent with the hypothesis
that PA subunit is preferentially bound to a subunit when both P subunits are
expressed in the species studied, and that inhibin B is only secreted in the absence of
PA protein.
To further examine the hypothesis that inhibin and activin may influence
ovarian function through paracrine and autocrine actions, differences in the expression
of inhibin subunits in ewes carrying the fecundity gene, which leads to precocious
follicular maturation, were examined. It was noted that expression of both a and PA
subunits was significantly lower in medium sized antral follicles in carriers of the
mutation. Furthermore, the level of diffusion of PB subunit from medium and large
antral follicles was significantly higher in animals carrying the fecundity gene. The
level of PB-subunit associated proteins diffusing from the granulosa cells is increased
in antral follicles, possibly reflecting an increase in activin diffusion which may affect
the growth of smaller follicles.
In conclusion, this work has 1) identified the sources of inhibin A in the ovine
ovary; 2) provided evidence for the possible diffusion of activins throughout ovarian
tissue; 3) supported the hypothesis that the ewe does not produce inhibin B; 4)
reported a possible increase in activin diffusion from specific follicle populations in
ewes with increased ovulation rates; and finally 5) shown that in some species there
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Chapter 1 - Literature Review
Folliculogenesis, the process of follicle development to a pre-ovulatory stage, is
known to be regulated by a large number of endocrine, paracrine and autocrine
factors. The growth of follicles is initially reliant upon local ovarian stimuli with
dependency shifting to the gonadotrophins FSH and LH later in development.
Selection of a particular follicle from a numerous cohort is required for
ovulation to occur during the oestrous cycle. This selection involves intricate
signalling via ovarian molecules and pituitary gonadotrophins, resulting in the
development of a single ovulatory follicle in monoovular species with polyovular
animals maintaining several preovulatory follicles.
Although the roles of a majority of the molecules involved in this process have
been extensively researched, at present the precise mechanisms surrounding the
phenomenon of follicle selection have yet to be elucidated.
For the purpose of this review, the sheep will be the main species discussed
with comparative references to a number of other animals.
1.1 Folliculogenesis
In the sheep, adult ovaries contain a follicular reserve of between 12,000-86,000
primordial follicles (at two years of age) with a further 50-400 follicles at various
stages of development (Turnbull et al., 1977) (Cahill et al., 1979).
The formation of primordial follicles from germ cells takes place during fetal life
after the migration of germ cells to the genital ridge and differentiation of the gonads
has taken place (Mauleon, 1978). Members of the TGF(3 protein superfamily are
reported to be essential in the early development and organization of the ovary, with
bone morphogenetic proteins 4 and 8 (BMP4/8), produced by neighbouring somatic
cells, being key factors in the generation of the primordial germ cells (Ying et al.,
2000).
Oocytes, which are arrested in prophase I of meiosis, are enclosed in a layer of
flattened pre-granulosa cells leading to the formation of the first primordial follicle
around 75 days into gestation (Peters et al., 1975) with 91% of the ooctytes
1
incorporated into primordial follicles by day 135, just prior to birth. This is in
contrast to early follicular development in other species such as rodents and rabbits,
where the primordial pool develops in the early neonatal period (Marion and Gier,
1971).
The oocyte itself plays a highly significant role in the formation of a primordial
follicle. The recent discovery of the transcription factor Figa (factor in the germline
a) has identified an oocyte specific molecule necessary for the formation of a
primordial follicle (Soyal etal., 2000). Figa induces the expression of proteins which
contribute to the zona pellucida (ZP), and it has been suggested (Richards, 2001) that
the expression of the ZP proteins may be essential for the physiological connection
of the oocyte to pre-granulosa cells.
When the primordial cohort has developed, follicles are gradually selected for
further growth and small numbers constantly leave the quiescent stage and resume
growth.
In the ovine ovary, it is estimated that eight primordial follicles disappear from
the follicular reserve every day, and that only two or three of these follicles continue
their growth, with the other five or six being lost through cell death (Driancourt et al.,
1985). The length of time taken for an ovine recruited follicle (with three layers of
granulosa cells) to reach an ovulatory stage was originally estimated to be
approximately 6 months (Cahill and Mauleon, 1980), however, recent studies using
an autograft model have shown that this period may be as short as 2-3 months
(Campbell et al., 2000).
McGee and Hsueh (McGee and Flsueh, 2000) suggest that the process of
folliculogenesis can be regarded as a continuous activation of resting follicles from the
quiescent reserve, termed initial recruitment, with waves of hormone stimulation
leading to further cyclical recruitment of antral follicles throughout the oestrous cycle.
1.1.1 Initial recruitment
When a primordial follicle is activated, RNA synthesis occurs along with the
proliferation of the pre-granulosa cells surrounding the oocyte (Picton, 2001). The
follicle is now committed to further growth and cannot regress to its prior quiescent
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state. These activated follicles are now destined to either ovulate or become atretic,
the fate of the vast majority being the latter (McNatty et al., 1982).
Relatively little is known about the mechanism of initial follicle recruitment,
however, in many mammals there is a distinct relationship between the number of
follicles in the quiescent state and the number of growing follicles (Gougeon et al.,
1994). In the ovaries of young mammals, the follicular reserve is large and thus the
number of growing follicles is high. As the ovary ages the number of growing follicles
declines along with the size of the reserve. Conversely, the proportion of early
growing follicles in murine and primate ovaries increases with age (Krarup et al.,
1969; Gougeon et al., 1992), suggesting the possible removal of an autocrine
inhibitory factor produced by resting primordial follicles. This theory is supported
by research showing that growth is initiated in a high percentage of bovine primordial
follicles in vitro, compared to that seen in vivo (Wandji et al., 1996), suggesting that
factors originating from developing follicles are responsible for the inhibition of
recruitment.
The factors involved in this gradual and seemingly tightly controlled process
remain largely unknown and along with the suggestion of a decline in an inhibitory
factor, numerous stimulatory factors have been identified. The origin of these
molecules seems to be the ovary itself, as recruitment to growth is possible in the
absence of pituitary-derived hormones in hypophysectomised animals (McNatty,
1992). Recent research has also indicated that vascularizing pieces of ovarian cortex in
vivo maintains follicular quiescence, whereas in vitro culture allows unrestrained
activation of primordial follicles (Fortune et al., 2000). There are numerous putative
factors which have been put forward as candidate recruitment initiators, including
basic fibroblast growth factor (van Wezel et al., 1995), nerve growth factor (Dissen et
al., 2001), c-kit and its ligand (Yoshida et al., 1997), and activin-A together with
components of the extracellular matrix (Oktay et al., 2000). In contrast, there have
been other molecules identified, such as anti-Mullerian hormone, which inhibit the
initiation of growth in primordial follicles (Durlinger et al., 1999).
Growth/differentiation factor-9 (GDF-9) is a growth factor expressed exclusively by
the oocyte and is present at all stages of follicular development, except in primordial
follicles (McGrath et al., 1995). Studies examining GDF-9 deficient mice recorded
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normal primordial and early primary follicle growth, however, the knockout caused a
total block in development beyond this stage, leading to complete infertility (Dong et
al., 1996). Oocyte growth and the formation of the zona pellucida were unaffected in
these animals but significant changes in oocyte differentiation were noted.
Hirshfield (1991) suggested that recruited follicles are able to grow and develop
readily in the presence of basal levels of gonadotrophins, metabolic hormones and
growth factors until a certain point. They then reach the end of their lifespan under
these conditions and for continued growth to occur, and for follicles to avoid
becoming atretic, they must receive additional specific signals.
1.1.2 Cyclic recruitment (Selection)
Once recruited, early follicles are able to grow due to trophic stimuli from local
ovarian factors (review; Roche, 1996). These follicles (0.1 to 2.5mm in the sheep) are
late preantral and small antral follicles, which express FSH receptors on their
granulosa cells and LH receptors on their theca cells, and are able to generate a trophic
response in the presence of gonadotrophins (McNatty, 1992). This class of follicles
is thus termed gonadotrophin-responsive, as gonadotrophins are not essential for
their growth and development (Cahill, 1981). However, as follicle growth continues
the small antral follicles become increasingly reliant upon FSH and LH as their
trophic stimulants.
Shortly after the formation of the antrum, filled with follicular fluid, which
occurs when the follicle is between 0.2-0.4mm (Turnbull, et al., 1977), the follicular
cells begin to grow and differentiate rapidly. This considerable increase in growth
when the follicle is between 0.7 and 1.5mm in diameter is highlighted by a high
mitotic index at this time, which reaches a peak at 0.85mm (Cahill and Mauleon,
1980) and then decreases gradually until reaching near zero in preovulatory follicles.
Research has shown that follicles with a diameter greater than 2.5 mm require
gonadotrophins for continued growth (Dufour et al., 1979) and that FSH is more
essential during this period than LH. Although FSH is the more important
gonadotrophin in early follicular development, with LH becoming increasingly
significant later in the process, both hormones exert their effects in follicular cells via
the cyclic-AMP (cAMP) signalling pathway (Yong et al., 1992). This dual-signalling
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through the same molecule is possible due to the variation in cAMP tone within the
cell. A low tone, associated with FSH, seems to favour aromatase expression and cell
growth, with LH inducing a high cAMP tone, favouring progesterone production and
a decrease in cell growth.
In addition to gonadotrophins, the insulin-like growth factor (IGF) system has
been shown to play a key role in the regulation of follicle development at the point
follicles become responsive to FSFI and LH. IGF-1 has been shown to potentiate the
action of FSH on granulosa cells by increasing the expression of FSH receptor in
murine ovaries (Zhou et al., 1997). The importance of the IGF system in follicular
survival is highlighted by the fact that healthy follicles have a high level of
bioavailable IGF in their follicular fluids, in contrast to atretic follicles which have
an increased level of IGF-binding proteins (IGFBPs) and therefore reduced levels of
free IGF (Monget et al., 1996). In addition, large oestrogenic follicles have very low

















Figure 1.1 Initial and cyclic recruitment of follicles within the ovary, showing the
continuing depletion of primordial follicles and regular selection of ovulatory
follicles from a secondary cohort. (Modified from McGee and Hsueh, 2000).
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1.1.3 Dominance
Early research in the sheep (Smeaton and Robertson, 1971) identified the
development of a follicle of preovulatory size at three points during the cycle; day 6-
9, day 13 and 1-2 days before the onset of next oestrus. The growth of these follicles
is due to waves of cyclical recruitment occurring at regular intervals throughout the
oestrous cycle (Evans et al., 2000), leading to the repeated development of a cohort
of large antral follicles. In response to the hormonal environment one or more of these
follicles are able to become 'dominant' over the other selected antral follicles.
The dominant follicle is so called as increasing evidence suggests that once
selected it is able to suppress further growth by other subordinate follicles within the
ovine ovary (Campbell et al., 1999a; Driancourt et al., 2000). The expression of LH
receptors on the granulosa cells (Webb and England, 1982) and increased oestradiol
secretion are markers of the dominant follicle and are of paramount importance to its
survival. The increased vascularisation of the theca compartment of the follicle is also
likely to play a part in the ability of the follicle to continue growth.
The theca cells of dominant follicles in the cow release greater quantities of
androgen, and granulosa cells are able to convert significantly more androgen to
oestradiol than the same cells from non-dominant follicles (Turzillo, 1992).
The dominant follicle is able to avoid the atretic fate of the other recruited
follicles due to its capacity to survive the low levels of FSH, induced by increasing
levels of both ovarian oestradiol and inhibin. The follicle destined to become
dominant may be able to generate trophic cAMP levels within the granulosa in
response to LH (due to the expression of LH receptors on the granulosa cells)
utilising it as a surrogate for declining FSH (Yong, et al., 1992). Research has shown
that ovulatory follicles are able to transfer their dependency from FSH to LH in order
to survive the switch in gonadotrophic support (Campbell et al., 1999b). The
capability of these follicles to make this change is therefore thought to be essential to
the mechanism of follicle selection. Additionally, recent research working with bovine
follicles has identified the level of insulin-like growth factor biding protein-4 (IGFBP-
4) as a predictor of the dominant follicle (Fortune et al., 2001). A decrease in this
protein caused by FSH-induced up-regulation of IGFBP-4 protease in dominant
follicles leads to greater bioavailability of IGF, which in turn enhances the follicles
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responsiveness to FSH. The ability of specific follicles to decrease levels of IGFBP-4
is thought to be essential to the emergence of dominant follicles.
The transition of the dominant follicle to a preovulatory follicle, which is
capable of initiating a surge of LH from the pituitary, may be due to the increase in
LH pulse frequency during the follicular phase. This additional stimulus from LH is
not present during the luteal phase and may explain why dominant follicles are unable
to produce the levels of oestradiol necessary for the instigation of an LH surge and
thus ovulation at this time.
It is clear that the follicular environment is responsible for the selection of
certain follicles for continued development and the aversion of atresia, but not why
one follicle is preferred to another at the same stage of growth.
1.1.4 Atresia
The fate of the vast majority (>99%) of ovarian follicles is to undergo the
process of cell loss known as atresia (Arai, 1920), the underlying mechanism of
which is apoptosis (Hughes and Gorospe, 1991). Atresia begins with the ovum
undergoing cytolysis and the membrana granulosa is cast off into the follicular fluid
and eventually reabsorbed. The theca cells surrounding the follicle proliferate and
form a yellowish shell and the follicular fluid begins to dissipate from the antrum.
Eventually the follicular walls collapse leaving an entity similar to that found at the
latest stages of corpus luteum degradation. There are numerous morphological
markers of follicular atresia, including detachment and degeneration of the granulosa
cell layer (Hughes and Gorospe, 1991), the appearance of pyknotic nuclei in the
granulosa compartment (Hirshfield and Midgley, 1978), fragmentation of the basal
lamina (Bagavandoss et al., 1983), decreased follicular oestradiol production (Carson
et al., 1981) and decreased binding of FSH and LH (Uilenbroek et al., 1980).
Furthermore, research has shown that messenger RNAs for gonadotrophin
receptors and P450 aromatase (Tilly et al., 1992), are selectively decreased in atretic
porcine follicles and that apoptosis occurs in both the theca and granulosa cell types.
Recent studies have identified the roles of the cell death promoters P53 and Bax
(Zwain and Amato, 2001), which are both induced by cyclic AMP (cAMP) in atretic
follicles, and the Fas pathway (Porter et al., 2001) in the regulation of follicular
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atresia. The level of Fas and Fas-ligand (FasL) are significantly higher in atretic
follicles and subordinate follicles have an increased sensitivity to FasL.
1.2 Gonadotrophins
Fevold and colleagues (Fevold, 1931) first reported that a pituitary
gonadotropic fraction from postmenopausal women contained two active
components, follicle stimulating hormone (FSH) and luteinising hormone (LH).
Secretion of FSH and LH from the anterior pituitary is stimulated by
gonadotrophin-releasing hormone (GnRH), a decapeptide secreted by hypothalamic
neurons. Release of GnRH has been shown to be influenced by numerous
hypothalamic factors including noradrenaline, adrenaline, catecholamines and more
recently activin-A (Calogero et al., 1998).
FSH and LH are glycoprotein hormones composed of two subunits, a and p.
The a subunit is conserved between the two molecules and is linked non-covalently
to one of two structurally unique p subunits which confer a high degree of
biochemical and biological specificity to the hormones (Mercer and Chin, 1995). FSH
and LH are produced by gonadotrope cells, which account for 7-10% of all cells in
the anterior pituitary gland (Marshall, 1989). The physiological half-life of the two
hormones differs considerably, with LH measurable in ovine circulation for
approximately 20-30 minutes and FSH exerting its effects for 130-160 minutes
(McNeilly, 1988). However, if sufficient quantities of gonadotrophin are released by
the pituitary or introduced experimentally, the hormones may be biologically active
for longer periods.
1.2.1 Gonadotrophin Secretion
The pattern of release of the two gonadotrophins is considerably different. LH
is released by the anterior pituitary gonadotropes in a pulsatile fashion through a
regulated pathway (Farnworth, 1995) in response to a rise in the level of intracellular
calcium caused by the binding ofGnRH to the gonadotrope.
FSH, unlike LH is not stored in considerable amounts in the gonadotropes and
60-80% of FSH produced daily is secreted into the circulation, compared with 1-8%
of total LH synthesized (Fraser et al., 1981; McNeilly et al., 1982; McNeilly, 1985).
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The release of FSH is therefore primarily constitutive with the small amount of
protein stored being released along with LH in response to a pulse of GnRH from the
hypothalamus.
Release of gonadotrophins from the pituitary is primarily induced by GnRH
pulses from the hypothalamus. However, several other factors are able to modulate
their secretion. It has been shown in the sheep that FSH release is potentiated by a
negative feedback loop involving oestradiol and inhibin (Baird et al., 1991). These
two ovarian products act by down-regulating FSH subunit mRNA transcription in
the gonadotropes (Carroll et al., 1991a). Oestradiol, together with progesterone has
the capacity to act in a negative feedback system to suppress the release of LH from
gonadotrope cells (Karsch et al., 1987). In cultured ovine pituitary cells, it has been
shown that oestradiol affects a specific number of predetermined cells to inhibit FSH
synthesis and increase responsiveness to GnRH (Ghosh et al., 1996). In contrast,
inhibin is able to completely abolish FSH production in some cells whilst modulating
GnRH and LH receptor expression in others.
1.2.2 Gonadotrophin action
Granulosa cells in the female, and Sertoli cells in the male are the sole target
cells for FSH action and are the only cells which express FSH receptor (Simoni et al.,
1997). FSH and LH exert their effects on their target cells by binding to specific
hormone receptors, both of which are members of the G-protein coupled receptor
family (Ulloa-Aguirre and Timossi, 1998). These receptors are glycoproteins
characterized by an external N-terminal ligand binding domain, seven a-helical
transmembrane domains and several intracellular domains, the last of which is
involved in G-protein linked signal transduction and activation of the adenylyl
cyclase-protein kinase A signalling pathway (Marsh, 1976; Ratoosh and Richards,
1985; Reichert and Dattatreyamurty, 1989). FSH and LH are also able to increase
intracellular calcium ion concentrations, activating calmodulin kinase and protein
kinase C signalling pathways respectively (Gudermann et al., 1992; Flores et al.,
1998).
Shortly after the ligand binds to its receptor, and intracellular signalling has
been initiated, the ligand-receptor complex is internalised by endocytosis and broken
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down by lysosomes. The free receptor may then be recycled back to the cell
membrane by exocytosis (Catt, 1996).
1.3 Steroidogenesis in the Follicle
Steroidogenic pathways present in the granulosa and theca cells of ovarian
follicles are responsible for the synthesis of the systemically active sex-steroids
which directly and indirectly influence follicular growth and development.
When an ovine ovarian follicle reaches a diameter of around 3 mm, a dramatic
shift in steroid production occurs. Prior to this point, the levels of both oestradiol
(E2) and androstenedione (A4) are relatively low compared with testosterone (Carson,
et al., 1981). The shift in steroid synthesis leads to a rapid increase in oestradiol
production and a decrease in the level of testosterone, coinciding exactly with the first
expression of LH receptor on the granulosa cells (Carson et al., 1979). However, not
all follicles are able to respond in this way and although their steroid content remains
comparable with healthy follicles, they do not show the increase in oestradiol output
characteristic of healthy follicles (Tsonis et al., 1984a) and undergo atresia after the
ovulatory follicle has been selected.
The steroidogenic pathway in follicles is split between the granulosa and theca
cell compartments (Figure 1.2), with both cell types being necessary for the
production of oestradiol (Hsueh et al., 1984).
Ovarian steroid production relies on both de novo production of cholesterol as
well as the utilization of cholesterol from the circulation, with the process being
controlled by both systemic and locally produced trophic hormones. Acquisition of
cholesterol is the first rate-limiting step in the synthesis of ovarian steroids. Delivery
of cholesterol into follicular cells is controlled by the hormonally inducible (Clark et
al., 1994) steroidogenic acute regulatory protein (StAR). The StAR protein is
responsible for the translocation of cholesterol from the cytoplasm of the cell to the
inner mitochondrial membranes, where the first steps of steroid synthesis occur.
Cholesterol is obtained primarily from lipoproteins in the serum which bind to
specific membrane receptors enabling its uptake and storage (Ikonen, 1997).
The first enzymatic step in the production of steroids involves cytochrome
P450 cholesterol side-chain cleavage (P450scc) in the conversion of cholesterol to
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pregnenolone, in a reaction which is induced primarily by LH and also by insulin¬
like growth factor I (IGF-1) and FSH (deMoura et al., 1997; LaVoie et al., 1999).
For the synthesis of progesterone to occur, another enzyme, 3§-
hydroxysteroid dehydrogenase (3P-HSD) needs to be present. Further processing of
the steroid is carried out by cytochrome P450 17a-hydroxylase (P450ci7). In ovine,
porcine and bovine follicles this enzyme is found exclusively in the theca interna
cells (Conley et al., 1995) and is responsible for the generation of the main ovarian
androgens, androstenedione and testosterone, by cleaving 21 carbon steroids
(progesterone) to 19 carbon androgens.
Figure 1.2 The steroidogenic pathway in ovarian follicular cells.
Although the granulosa cells of the ovarian follicle lack the enzymes necessary
to produce androgens, they are essential in the conversion of thecal androgen to
oestradiol by way of another enzyme, cytochrome P450 aromatase (P450arom). It
has been suggested that this reaction occurs mainly in the granulosa cells adjacent to
the basement membrane (Baird and McNeilly, 1981), as the androgen substrate on
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which P450arom acts is produced by the theca compartment. Aromatase has been
shown to be selectively inhibited by follicular fluid from the dominant follicle in
sheep (Campbell, et al, 1999a), suggesting the presence of a factor produced by
dominant follicles which reduces oestradiol production by other subordinate follicles.
The involvement of both the granulosa and theca compartments in the final
production of oestradiol is referred to as the' two-cell, two-gonadotrophin theory.' In
the thecal cells, LH is the primary modulator of P450scc, with FSH in parallel, the
controller of P450arom in the granulosa cells (Gore-Langton, 1994; Hillier et al.,
1994).
1.4 Oestrous Cycle of the Ewe
After a period of sexual inactivity (anoestrus) in the ewe throughout the
summer months, the onset of sexual activity in the autumn is related to the shortening
of the photoperiod which is tracked closely by the pineal gland of the animal
(Woodfill et al., 1994). The resumption of breeding activity is characterized by a
short period of hormonal signalling leading eventually to ovulation (Legan et al.,
1977). A dramatic fall in progesterone release brought about by a rise in prostaglandin
F-2a (PGF-2a) leads to firstly an increase in the level of oestradiol and in turn to a
period of sexual receptivity (Barrett et al., 1971), termed oestrus. The feedback of
oestradiol to the anterior pituitary brings about a change in the pulse amplitude of LH
resulting eventually in ovulation (Scaramuzzi, 1975).
The periods of sexual activity during the autumn and winter months are
punctuated with regular cycles of oestrous activity at intervals of approximately 17
days with the day of onset of oestrus designated as day 0 (Figure 1.3). These cycles
are normally divided into the luteal phase which lasts from ovulation on day 1, to the
regression of the corpus luteum (luteolysis) on day 14, and the follicular phase which
represents the three day peri-ovulatory period from luteolysis to ovulation (Baird
and McNeilly, 1981).
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The presence of a corpus luteum (CL), the post-ovulatory residual mass of
follicular cells, in at least one ovary is characteristic of this phase of the ovine cycle.
The CL is responsible for the secretion of a high level of progesterone which
increases steadily from the time the CL is formed on day 1, to reach a peak between
days 6 and 12 (Herriman et al., 1979) (Figure 1.3).
The ovine CL produces almost only progestagens, and in contrast to primates,
does not release either oestradiol (Baird et al., 1975) or inhibin (Mann et al., 1989).
The main role of progesterone produced by the CL is to prepare the uterine
endometrium for implantation and to maintain early pregnancy.
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Progesterone secretion by the ovine CL has been shown to be sustained by
basal levels ofLH in the absence of its pulsatile release (McNeilly and Fraser, 1987).
The high level of circulating progesterone in the periphery acts synergistically with
oestradiol in a negative feedback loop to reduce LH pulse frequency from the
pituitary (Martin et al., 1988), thus enhancing its own release and suppressing
ovulation during the lifespan of the CL.
It has been suggested that oestradiol induces an increased sensitivity of the
central nervous system to the negative feedback action of progesterone (Goodman et
al., 1981a) and that progesterone decreases the frequency of LH pulses from the
pituitary by reducing the frequency of GnRH pulses from the hypothalamus
(Tamanini et al., 1986).
The decrease in LH pulse frequency leads to a reduction in androgen synthesis
in the theca compartment of ovarian follicles and thus to a decrease in oestradiol
production by large follicles.
The CL undergoes the process of luteolysis if there is no embryo present in the
uterus. The series of events leading to the regression of the CL is primarily controlled
by oxytocin, produced by the magnocellular hypothalamic neurons and stored in the
pituitary, and prostaglandin F2-a secreted by the uterine endometrium (Alwachi et
al., 1981). Progesterone acts to prime the uterus for a period of 7-10 days prior to
PGF2-a release by the endometrium (Baird, 1978a). Oxytocin acts on its receptor in
the endometrium to stimulate the secretion of PGF2-a which is widely considered to
be the main luteolytic agent in the ewe (Umo, 1975; Horton and Poyser, 1976). In
addition, the action of PGF2-0C on the ovine CL is mediated by the arterial
vasoconstrictor peptide, endothelin 1 (Milvae, 2000).
1.4.2 Follicular Phase
During the three day period between luteolysis and ovulation, the ovary is
subjected to a continuous rise in LH pulse frequency from the pituitary (Baird,
1978b) due to the fall in plasma progesterone after the regression of the CL
(Goodman et al., 1981b), with LH pulse amplitude remaining low (Baird et al., 1981).
The immediate effect of the increase in LH release is the induction of the maturation
of one or more healthy antral follicles (Baird and McNeilly, 1981). It has been
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suggested that progesterone withdrawal is not the only factor responsible for the high
LH pulse frequency during this stage of the cycle and that the effect of pulses of
oestradiol secreted by the ovary in response to the increasing LH pulses, is also
highly significant (Karsch et al., 1983). The level of oestradiol secreted by the ovary
eventually reaches a high enough concentration to bring about oestrus behaviour, and
triggers the LH surge around 4-8 hours later (Cumming et al., 1973). The surge of LH,
lasting between 10-18 hours, induces ovulation approximately 32 hours after the
onset of oestrus (Souza, 1994). Ovulatory follicles are derived from large follicles
(>2mm) present at the time of luteal regression, however, several reports have shown
that if only small follicles are present at this time, the lifespan of the CL may be
extended by 24 hours to allow them to develop and ovulate (Tsonis et al., 1984b;
Souza et al., 1997a), suggesting that follicle selection in the ewe may occur prior to,
or after the regression of the corpus luteum.
In addition to the modulation of LH pulses during the follicular phase, the
increase in follicular oestradiol and inhibin secretion, primarily from the dominant
follicle(s), has a negative effect on the release of FSH by the pituitary (Campbell et
al., 1990). Considering recent evidence that FSH modulates early folliculogenesis
(Campbell et al., 2000), this reduction in FSH concentration may serve to suppress
the recruitment of further follicles and to provide an environment able to select out
follicles with the cellular machinery to survive.
1.4.3 Variation in Ovulation rate
The number of ovulations per ovine oestrous cycle, or the ovulation rate (OR),
varies considerably from 1 to >10 eggs shed every seventeen days. There are
numerous factors which have been shown to affect OR including age (McKenzie,
1937), body weight (Findlay and Cumming, 1976), season (Wheeler et al., 1977) and
breed. The sheep is able to vary its OR by extending the length of time to which
recruited follicles are exposed to a high enough level of FSH (McNatty and
Henderson, 1987) and by the simultaneous maintenance of several follicles able to
survive the fall in FSH (Baird and Campbell, 1998), characteristic of the early
follicular phase of the cycle. There is also a suggestion that an increase in the
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bioavailability of local factors such as IGF-1 (Monniaux et al., 2000) may lead to
increased ovarian responsiveness to gonadotrophins.
One of the most prolific ovine phenotypes known is that of the Booroola ewe
which evolved from particular lines of the Merino breed in Australia. A gene
responsible for the high OR in these animals has been designated the Booroola
fecundity (Fee8) gene (Davis, 1982). Ewes homozygous for this gene have an OR
which is more than double that of wild type animals (>5, compared to 1 or 2), with
heterozygotes having an OR of 3 or 4.
This elevation in OR is due to the precocious maturation of small antral follicles
which become oestrogenic and express LH receptor on their granulosa cells when
they are 2.5-3.5mm in diameter, compared to 4-6mm in wildtype (non-gene carrier)
animals (Henderson et al., 1985; McNatty et al., 1986). In addition, it has been
shown that there are decreased rates of atresia in large growing follicles of Fee8
carriers compared to wild type animals (Mandiki et al., 2000)
Several reports have shown that the Fee8 gene makes no difference to the
hormonal output of the ovary (McNatty, et al., 1986; Souza et al., 1997b), and
although ovulatory follicles are smaller in gene carriers there are a greater number
leading to an equivalent number of granulosa cells in oestrogenic follicles overall
(McNatty et al., 1985). In contrast to ovarian data, a higher frequency of high-level
FSH is seen in the plasma of Fee8 animals (McNatty and Henderson, 1987) resulting
in an extended period of recruitment. Although these observations indicate some of
the differences evident in these animals, the protein for which the Fee8 gene codes,
and the precise mechanism of its physiological effects have remained unknown until
recently.
The Fee8 gene has been mapped to chromosome 6 in the sheep (Montgomery
et al., 1994) and recent studies (Souza et al., 2001; Wilson et al., 2001) have
investigated a candidate gene in the same region of the chromosome as the Fee8 locus.
This selected gene codes for the bone morphogenetic protein receptor (BMPR)
type IB also known as activin-like kinase-6 (ALK-6) which binds members of the
TGF-p superfamily and initiates gene transcription through the intracellular Smad
protein cascade, which will be described later in this review.
Identification of two point mutations highly specific to carriers of the Fee8
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gene in the kinase domain of this receptor (Souza, et ah, 2001), suggests that the
downstream signalling of the ALK-6 receptor may be disrupted in these animals.
This alteration in BMP signalling, essential in mammalian embryogenesis, may well
result in the Booroola phenotype. Recent work supporting this hypothesis has
studied the response of granulosa cells from animals homozygous for the Fee8 gene to
ALK-6 ligands. These cells were less responsive to the inhibition of steroidogenesis
by GDF-5 and BMP-4 compared to cells from non-carrier ewes (Mulsant et al.,
2001) suggesting that the ALK-6 mutation may be responsible for the advanced
maturation of ovulatory follicles in Fee8 animals.
1.5 Inhibin
Forty years after first being described, numerous studies in the 1970's
accumulated evidence for the existence of the non-steroidal hormone, inhibin, and of
its ability to suppress FSH secretion by the anterior pituitary (De Jong and Sharpe,
1976; Keogh etah, 1976).
Further research revealed that inhibin is synthesized within the granulosa cells
of the mammalian follicle (and luteal cells in primates) (Roberts et al., 1993), either
accumulating in the follicular fluid (FF) or being secreted into the plasma. The
concentration of inhibin in follicular fluid increases with follicular size and is
correlated with aromatase activity in the granulosa cells and in turn the level of
oestradiol production (Baird, et al., 1991).
1.5.1 Properties
To date, two forms of inhibin (A and B) have been identified in the ovaries of
most species studied, including human, monkey, pig, rat and mouse. They are
members of the TGF-P superfamily of heterodimeric glycoproteins and consist of a
conserved a-subunit (around 32 kDa) linked by a disulphide bond to one of two (3-
subunits, pA or PB (14-18 kDa) (Ling et ah, 1985). Although PC, PD, and pE
subunits have been identified (Hotten, 1995; Oda et ah, 1995; Fang et ah, 1996), there
is little data available describing their physiological effects, with the exception of
research indicating that the PE subunit may have a role in liver function and
inflammation in the rat (O'Bryan et ah, 2000).
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Inhibin is synthesized by ovarian granulosa cells as a 105 kDa protein
comprised of an a and (3 subunit, which is then cleaved down into smaller dimers.
The a and (3 subunits are produced independently as large precursor proteins with
several processing sites (Forage et al., 1986) (Figure 1.4).
Separate genes code for the a, (3A and (3B precursors which are processed at
regions containing paired arginine residues to produce a 43 kDa a-subunit (aNaC)
and a 14-15 kDa [3-subunit. The 43 kDa chain is subsequently cleaved to yield a
reduced 20 kDa a-chain which is found in 32 kDa inhibin. These steps may occur
before or after dimerisation with the (3-subunit; however, the fact that contact with
serum results in the synthesis of the 32 kDa form (McLachlan et al., 1986) suggests
the involvement of a controlling factor in the circulation.
A variety of molecular forms of inhibin have been identified in the human
(Sugino et al., 1992; Good et al., 1995; Mason et al., 1996), including mature (32-
kDa), partially processed (3-precursor dimers and biologically inactive forms of the
a-subunit (Knight et al., 1989;Lambert-Messerlian et al., 1994).
Early methods employed in an attempt to measure inhibin levels (Rivier et al.,
1986; Sharpe et al., 1988; Campbell, et al., 1990) were targeted against the a-subunit
and so captured the biologically inactive free a-subunit forms as well as the
biopotent dimers, generating contrasting results. Recent advances have overcome this
problem with the development of highly specific two-site enzyme-linked
immunosorbent assays (ELISAs) which target the individual (3-subunits (Groome et
al., 1996; Robertson et al., 1997).
Investigations utilising these new procedures have shown that in primates there
is a changing pattern in mRNA expression relating to the inhibin subunits (Fraser et
al., 1993). Expression of the (3B-subunit is highest in antral follicles and is consistent
with the production of activin. In the corpus luteum, alpha subunit is predominant
over low (3-subunit expression and supports the production of inhibin by the corpus
luteum in the primate.
During the purification of inhibin from follicular fluid, two further molecules
(also produced by granulosa cells), termed activin and follistatin (FSP), were
identified as additional modulators ofpituitary FSH release (Ling et al., 1986; Vale et
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al., 1986; Robertson et al., 1987). Activin was identified as a disulphide-linked
dimer of two inhibin p-subunits (Mr 25,000), existing as either activin A (pA-pA),
activin B (PB-pB) or activin AB (PA-pB). Activin stimulates pituitary FSH release
and enhances FSHp mRNA expression by stabilising the protein (Carroll et al.,
1991b), therefore having the opposite effect to inhibin on the pituitary.
Follistatin is a glycoprotein chain encoded by a single gene with no homology
to either inhibin or activin (Shimasaki et al., 1988). Various forms of follistatin with
molecular weights between 32 and 39kDa have been identified, each having the
capacity to bind to activin, and to a lesser extent, inhibin through their common p-
subunits (Nakamura et al., 1990; Shimonaka et al., 1991). Thus, follistatin is able to
influence the paracrine/autocrine action of these molecules by modulating their
bioavailability (Xiao et al., 1992; Findlay, 1993). It has been shown that FSP
production is up-regulated in rat granulosa cells by FSH and activin, possibly
through the protein kinase A and C pathways (Shintani et al., 1997).
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Figure 1.4 Forms of inhibins and activins
In order to learn more about the local and systemic actions of inhibins and
activins, it is necessary to review the literature concerning the discovery of their
receptors and associated signalling pathways.
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1.5.2 Receptors for Inhibins and Activins
A number of the physiological actions of inhibin are directly counteracted by
the presence of activin (Ling, et al, 1986), however, the fact that one protein is able
to exert effects on tissues in the presence of the other, with no antagonism, suggests
the presence of specific receptors and signalling pathways for both hormones.
The first real breakthrough in the search for activin and inhibin receptors came
in the early 1990's with the identification and cloning of an activin type II receptor
(ActRIIA) which bound activin A and B with high affinity, as well as inhibin A
(Mathews and Vale, 1991). The type II activin receptors (ActRIIA and the highly
homologous ActRIIB) are serine/threonine kinase receptors with a single
transmembrane domain (Attisano and Wrana, 1998; Piek, 1999). Binding of activin
ligand to a type II receptor leads to the recruitment of a TGF-[3 superfamily type I
receptor, such as activin-like kinase-4 (ALK4/ActRIB) or activin-like kinase-2 (ALK-
2/ActRI) and forms a heteromeric receptor complex (Carcamo et al., 1994). Within
this complex, the type II receptor phosphorylates the TGF-(3 type I receptor on
serine and threonine residues within the cytoplasmic domain, close to the
transmembrane region, in order to induce activation (Attisano et al., 1996). The
activated type I receptor subsequently propagates the signal by phosphorylating
downstream proteins, including the Smad (Mothers against DPP) transcription
factors (Liu et al., 1996) (Figure 1.5a). Three groups of Smad proteins have been
discovered; the receptor Smads, which are phosphorylated by type I receptors;
inhibitory Smads which inhibit this process of receptor Smad activation by binding to
the type I receptor (Lebrun et al., 1999); and finally the common mediator Smad,
Smad 4. Activin and TGF-J3 ligands signal through the receptor Smads, 2 and 3
(Eppert et al., 1996; Graff et al., 1996; Zhang et al., 1996), with bone morphogenetic
proteins (BMPs) signalling through Smadl, Smad5 and Smad8 (Massague and Chen,
2000). The phophorylation of Smad2 or 3, by the type I receptor after the binding of
activin, is modulated by the inhibitory Smad, Smad7 (Lebrun, et al., 1999). Once
activated, the receptor Smads (r-Smads) are able to form trimers with Smad 4. These
complexes then translocate to the cell nucleus where they induce expression of target
genes by binding to promoter elements within the cell's DNA (Derynck, 1998).
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Studies incorporating radioactively-labelled recombinant preparations of both
inhibin A and activin A revealed specific binding of both proteins to sites in the
ovary and testes of the rat (Woodruff et al., 1993; Krummen et al., 1994). Although
activin receptors had been identified at this time, receptors for inhibin remained
elusive.
Research carried out in parallel to the activin receptor studies identified several
factors capable of the high affinity binding of inhibin. Betaglycan, previously
regarded as a highly expressed type III TGF-(3 receptor, was unmasked as one of
these inhibin-binding proteins in the late 1990's (Lewis et al., 2000). Cells expressing
both betaglycan and ActRIIA were shown to bind inhibin with even greater affinity
than betaglycan alone leading to an increase in the antagonism of activin signalling by
reducing the bioavailability ofActRIIA receptor (Figure 1.5c).
Further research using an inhibin-A affinity column, identified an inhibin-
binding moiety, present in the target tissues of inhibin (Chong et al., 2000). This
protein, termed pi20 or inhibin binding protein (InhBP) was shown to be a
membrane-anchored proteoglycan, expressed concomitantly with FSH(3 in the
pituitary and Leydig cells of the rat. InhBP has no identifiable intracellular
serine/threonine kinase domain which distinguishes it from the other TGF-J3























I - Activin Type I Receptor (ActRI); II - Activin Type II Receptor; IR - Inhibin Receptor; BG - Betaglycan; P - Phosphorylation
Figure 1.5 Inhibin and activin signalling pathways, (a) Signalling mechanism of
activin binding to the type II receptors which recruit and phosphorylate type I
receptors. The internal signalling cascade is then initiated by the phosphorylation of
Smad2 or 3. (b) Inhibin signalling via inhibin receptor (pi20). (c) reduced
availability of type II receptor for activin signalling due to recruitment by the
betaglycan/inhibin complex.
1.5.3 Mechanism of Action
In all mammals studied, inhibin generates a dose-related suppression of FSH
release from the anterior pituitary with a slight suppression of LH levels seen at high
concentrations in some species (Farnworth et al., 1988). In contrast to GnRH
antagonists, inhibin has the ability to prevent both the preovulatory and secondary
FSH surges during the oestrous cycle.
Initially it was thought that inhibin exerted its effect on FSH release by acting
directly at the genetic level, by altering the level of FSHp gene expression in the
sheep (Mercer et al., 1987). However, further investigations on rat pituitary cells
carried out in vitro, indicated that inhibin decreases the stability of FSHp mRNA,
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with activin increasing its stability to exert its opposing effect (Attardi and Winters,
1993). Inhibin is able to modulate this action of activin in the pituitary by
specifically blocking the binding of the molecule to its receptor in Chinese hamster
ovary cells (Martens et al., 1997).
Although GnRH is responsible for the regulation of both FSH and LH
secretion, inhibin only modulates FSH and has no effect on the expression of LHP
mRNA in rat pituitary cells (Carroll et al., 1989). In addition, expression of LH
receptor mRNA is controlled by both oestradiol and progesterone in the ewe (Mann
etal., 1992).
In addition to their functions at the pituitary, there is considerable evidence
implicating inhibin and activins in paracrine and autocrine modulation within the
ovary.
1.5.4 Autocrine effects on Granulosa
Inhibin A binding sites have been identified on granulosa cells indicating a likely
autocrine action (Woodruff, et al., 1993). In agreement with this finding, an autocrine
effect of inhibin on the production of oestradiol by rat granulosa cells has been
recorded (Ying et al., 1986) and in cultured sheep granulosa cells inhibin enhances the
ability of FSH to induce aromatase (Campbell and Baird, 2001).
Investigations concerning the action of inhibin on granulosa cells are
complicated by the production and secretion of endogenous inhibin by the granulosa.
This has not, however, been a problem encountered during studies relating to the
effects of activin on granulosa cells, which have been well researched in several
species, although at this time no evidence is available for the ewe.
Activin has been shown to stimulate the in vitro growth of isolated preantral
follicles from immature rats, with similar follicles from adult rats showing no
response (Yokota et al., 1997).
In isolated rat granulosa cultures, activin is able to up-regulate FSH receptor
expression, enhance cellular responsiveness to both FSH and LH (Xiao, et al., 1992)
and also increase inhibin a-subunit and FSP mRNA expression (LaPolt et al., 1989;
Michel et al., 1992). In the presence of FSH, activin enhances aromatase activity
(Miro et al., 1991) and thus oestrogen production as well as progesterone secretion.
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These observations indicate that activin may play a significant role in the attainment
of FSH responsiveness by granulosa cells (Findlay, 1993), and has a role in the
continued development of follicles either responsive or reliant on stimulation via
FSH.
Treatment with FSP suppresses FSH-induced aromatase activity, inhibin
synthesis and increases FSH-induced progesterone production (Xiao et al., 1990;
Xiao and Findlay, 1991). It is important to note that other local ovarian factors
including IGF-1 (insulin-like growth factor), EGF (epidermal growth factor) and
TGF-a have been shown to affect the growth and differentiation of granulosa cells in
vitro, as well as the production and release of oestradiol and inhibin A (Campbell et
al., 1996a).
1.5.5 Paracrine effects on Theca
In preparations of cultured theca cells from the cow, human and sheep, inhibin
enhances LH-induced androgen production (Figure 1.6) with activin having the
opposite effect and suppressing this modulation (Hillier et al., 1991a; Wrathall and
Knight, 1995; Campbell and Baird, 2001). Incubation of whole (or sections of)
follicles with antibodies raised against inhibin, reduced androgen secretion (Smyth et
al., 1993). These observations suggest a role for inhibin in the maintenance of thecal
androgen production and in turn the supply of androgen substrate for the follicular
production of oestrogen in the granulosa. This modulatory effect of inhibin may be
significant with respect to oestrogenic follicles in the ovary assuming dominance.
As the dominant follicle emerges, production of inhibin and oestradiol-17(3 by the
ovary increases (Findlay et al., 1990), thus reducing FSH levels and restricting the
growth of other antral follicles. The dominant follicle is able to survive via the action
of local factors including inhibin, and IGF-1, which increase the responsiveness of
follicular cells to gonadotrophins (Campbell, 1999) thus compensating for the
decrease in FSH. In addition the dominant follicles may transfer their dependency
from FSH to LH due to the expression of LH receptor on the granulosa cells with LH
acting as a surrogate during this stage of the cycle. Subordinate follicles are not
























Figure 1.6 Molecular interactions between the compartments of the ovarian follicle.
1.5.6 Paracrine effects on Oocytes
Recent investigation has shown that cumulus granulosa cells express protein
and mRNA for all three of the inhibin subunits and FSP during in vitro maturation of
the oocyte (Izadyar et al., 1998; Silva and Knight, 1998). Expression of activin
receptors by oocytes has also been observed (Cameron et al., 1994; Sidis et al.,
1998). Inhibin subunit mRNA is only seen in cumulus cells, with expression of
inhibin-a and pA mRNA maximal in the cells adjacent to the oocyte (Braw-Tal,
1994). In contrast, inhibin protein was found in both the cumulus and the oocyte
(Imai et al., 1996). Furthermore, measurement of activin in oocyte-cumulus complex
culture medium revealed that morphologically good quality oocytes lead to the
production of higher levels of activin (Lau et al., 1999). These observations suggest
the involvement of activin in oocyte maturation in vivo, with its action potentiated by
inhibin and/or FSP.
1.5.7 Activin Diffusion
Research focusing on the action of activin signalling in the early Xenopus
embryo has revealed that activin has a long range signalling activity through tissue
and does so by forming a concentration gradient by diffusion through the cell layers
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(McDowell et al., 1997). By diffusing in this way, activin is able to activate gene
transcription in target cells in a concentration-dependent manner, acting like a
morphogen (Gurdon et al., 1999). If this is the case in the ovary, the diffusion of
activin from follicles may influence the growth and differentiation of other follicles in
a morphogen-like manner, with larger follicles having an influence on smaller
neighbouring follicles.
1.5.8 Control of Inhibin Secretion from granulosa cells
The release of inhibin is regulated by a large number of factors operating at
different levels including endocrine (FSH/LH), paracrine (EGF, TGF-a, INF-y,
androstenedione) and autocrine (IGF-1, TGF-(3, activin, FSP) molecules (Tate et al.,
1996; Tekmal et al., 1996; Bergh et al., 1997).
The presence of FSH in the follicular environment stimulates the synthesis and
secretion of inhibin by up-regulating the expression of mRNA coding for the a and
(3 chains (Rohan et al., 1991). Inhibin production by cultured rat granulosa cells is
responsive to both FSH and LH (Suzuki et al., 1987), whilst luteinised human
granulosa cells are stimulated by LH alone (Tsonis et al., 1987). In immature human
granulosa cells (those from small antral follicles) it is FSH which stimulates inhibin
production and not LH (sheep: Campbell and Baird, 2001) with the action of FSH
open to modulation by androgen (Hillier et al., 1991b).
These investigations show that the gonadotrophic control of inhibin production
varies as the follicle matures. The granulosa cells of small antral follicles do not
respond to LH, as they do not possess LH receptors via which inhibin production is
enhanced. However, as follicles develop, the expression of LH receptor on the
granulosa cells leads to responsiveness to both gonadotrophins.
The presence of pharmacological agents (cAMP, forskolin, phosphodiesterase
inhibitors, and prostaglandin E) able to increase the intracellular cAMP concentration
within the granulosa all stimulate inhibin production with a dose-response similar to
the gonadotrophins (Bicsak et al., 1986; Petraglia et al., 1987), suggesting FSH and
LH increase inhibin production via the adenylate cyclase system in conjunction with
specific cell-surface receptors.
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1.5.9 Molecular weight forms of inhibin and activin
Much of the early work carried out to investigate the in vivo action of inhibin
focused on the mature 32-kDa form of the protein (Tsafriri et al., 1989; Hillier, et al,
1991b; Schneyer et al., 1991). However, further research into the numerous other
molecular forms of inhibin revealed possible roles in follicular development.
Studies in the cow (Sugino, et al., 1992) characterized numerous inhibin forms
in follicular fluid, from a high molecular weight (105 kDa) precursor dimer to the
mature 32 kDa form of the protein. This research also suggested the serial processing
of the 105 kDa form, to smaller 95 and 55 kDa proteins before the final generation of
the mature 32 kDa. When added to cultured pituitary cells (Miyamoto et al., 1985),
the 32, 55 and 95 kDa forms were equally effective at suppressing FSH release.
However, there is a distinct possibility that the heavier forms are converted to the 32
kDa form in the culture system.
Transient mutation of the processing sites on the inhibin precursors (Mason, et
al., 1996) leads to the synthesis of non-cleavable varieties of high molecular weight
inhibins. Recombinant expression of human a and (3A subunit cDNAs in a
mammalian cell-line brings about the release of 20-53 kDa products derived from the
a subunit, 30-105 kDa dimers of a and (3A subunit forms and activin dimers with
molecular weights of between 24 and 110 kDa. Following the production of these
forms of inhibin and activin, their relative biological activities were analysed. The
non-cleavable 55 and 65 kDa forms of inhibin A were found to be fully biopotent in
terms of suppressing FSH release from rat pituitary cells. Conversely, the high
molecular weight (110 kDa) form of activin A had no measurable effect on FSH
release by rat pituitary cells and it is therefore suggested that the processing of this
dimer to the 24 kDa form is necessary to render it biologically active.
Further work examining the expression of various mass forms of inhibin by
dominant follicles during the luteal and follicular phase in heifers, identified seven
distinct proteins in the follicular fluid (Sunderland et al., 1996). The amounts and
proportions of these forms varies during atresia and pre and post the LH surge. When
considered along with data from in vitro studies which show high molecular weight
forms exerting effects similar to mature inhibin (Schneyer, et al., 1991; Ghosh,
1994; Padmanabhan et al., 1994), there is a strong suggestion that these molecules
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have a significant biological activity.
1.5.10 Inhibin Expression during the Oestrous cycle
To answer questions regarding the involvement of inhibin and its related
peptides in the regulation of the mammalian oestrous cycle it is helpful to study the
relative levels of the molecules during the considerable physiological and
morphological changes occurring in the ovary.
Although both inhibin A and inhibin B are able to suppress FSH release from
the pituitary, there is a suggestion that the two molecules have a greater functional
significance at different stages of the cycle (Lahlou et al., 1999).
In a number of species studied (including the human) a variation in the
expression ofmRNA coding for the different inhibin subunits has been shown during
the stages of follicle development. In the sheep, mRNAs for the a and (3B subunits
are evident in the granulosa cells of those follicles which have developed past the
primary stage, while (3A mRNA is only detectable in healthy antral follicles
(McNatty et al., 2000). Research examining the expression of inhibin mRNA during
the reproductive cycle showed little change in the production of signal for the
proteins (Tisdall et al., 1994). However, other workers (Engelhardt et al., 1993) have
reported a suppression of inhibin mRNA shortly after the LH surge, with no notable
staining for any subunit in the ovine corpus luteum.
In primates the expression of inhibin subunit mRNA is somewhat different, the
notable differences being that antral follicles express high level (3B subunit mRNA in
relation to the other two subunits suggesting the high-level production of activin, and
that the primate corpus luteum expresses mRNA for all three subunits (Fraser, et al.,
1993).
Measuring the levels of immunoreactive (ir) inhibin A and B produced by the
expression of these inhibin subunits has, as yet, not been possible in the sheep due to
the lack of a suitable assay for inhibin B; it has however, been carried out in other
species.
With respect to the levels of ir-inhibin A in the circulation during the human
menstrual cycle, levels are low in the early mid-follicular phase, rising in the late
follicular phase before falling shortly after ovulation and becoming maximal during the
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midluteal phase (McLachlan et al., 1987; Groome et al., 1994). These findings are
broadly similar to those recorded employing less specific inhibin assays and suggest
that in addition to oestradiol, inhibin A may be responsible for the control of FSH
secretion during the luteal phase and the initiation of follicular development during
the luteal-follicular transition (Hayes et al., 1998).
The levels of inhibin B in the human, however, do not follow the pattern
recorded in earlier assays (Welt et al., 1997). An early rise in its levels suggest that its
secretion is induced by the action of FSH on antral follicles, with research showing
that the addition of FSH to cultured rat granulosa cells leads to a dose dependent
increase in inhibin-B production (Lanuza et al., 1999). However, there is no clear
evidence as yet for its involvement in the regulation of FSH during the ovarian cycle.
A similar situation has been noted in the sheep, where it has been shown that
during the luteal phase there are three waves of follicular development all preceded by
an increase in FSH. The involvement of inhibin A and oestradiol has been described
in the control of FSH throughout the first wave of development. As the control
during the later waves is unknown and inhibin B has yet to be measured during the
ovine cycle, it has been suggested as a putative regulator of FSH release during waves
two and three (Souza et al., 1998). Recent studies have shown that contrary to the
male human, the ram does not produce inhibin B, and only synthesizes inhibin A
(McNeilly, 2000). Thus it is possible that the ewe does not produce inhibin B either
and that other factors modulate the later waves of follicle growth.
There are many questions still remaining surrounding the roles of inhibin in all of
the species studied. Although recent research has lead to the development of specific
assays for the two forms of inhibin, further work is necessary to determine the
precise involvement of the glycoproteins in the regulation of folliculogenesis
throughout the oestrous cycle.
At the time of writing this review, levels of inhibin A have been measured
throughout the ovine oestrous cycle, however, the specific source of the hormone in
the ewe has yet to be identified. In addition, the expression of the subunits bound
together to produce inhibins and activins has yet to be studied during the
reproductive cycle of the sheep. Research in these areas is necessary in order to
clarify the contribution of these proteins to the phenomena of follicle development
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and selection in this particular species. Furthermore, the involvement of inhibin-B, in
the mechanisms of this complicated process has yet to be elucidated, due to the lack
of a specific assay for this dimer in the sheep. Further work is required to confirm the
suggested influence of this protein in the control of the second and third follicular
waves in the ewe.
Although there is much evidence implicating inhibins and activins in the growth
and development of ovarian follicles, the possible involvement of these factors in the
growth of follicles in breeds of sheep with high ovulation rates has yet to be
researched.
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Chapter 2 - Materials and Methods
2.1 Experimental Animals
Scottish Blackface ewes used for the experiments in Chapters 3 and 4 of this
thesis were housed outdoors at the Marshall Building, Roslin, Mid Lothian,
Edinburgh. Additional tissue was obtained from a local abattoir and from in house
tissue collections.
2.2 Synchronisation of Oestrous cycles
The animals used during this research were taken from a spontaneously
cycling flock and therefore to enable ovariectomy to be carried out at precise points
during the oestrous cycle, the ewes were synchronised using medroxyprogesterone
acetate sponges (60 mg/sponge, Upjohn Animal Health Division, Crawley, Sussex,
UK) followed by i.m. injection of 100 pg cloprostenol, a potent prostaglandin F2a
analogue (Estrumate, Cooper's Animal Health Ltd, Crewe, Cheshire, UK).
2.3 Ovariectomy
Anaesthesia was induced by minimal quantities (200-300 mg) of a mixture of two
parts thiopentone (Intraval; RMB Animal Health Ltd, Dagenham, Essex, UK) and
one part pentobarbitone sodium (Sagatal; May and Baker Ltd, Dagenham, Essex,
UK) and maintained using halothane (1.5 - 2.5%). Mid-ventral laparotomy was then
performed, the reproductive tract exteriorised and the ovaries removed.
2.4 Blood Sample Collection
2.4.1 Jugular Venous Blood
The left jugular vein was cannulated under local anaesthetic (2ml s.c. of Lignocaine
2%, Lignavet, Leyland, UK) with a 60cm length of Silastic tubing (0.04 x 0.085
inches, internal and external diameters respectively; Osteotec Ltd., Christchurch,
Dorset, UK) filled with heparinised saline (10 IU/ml), which was inserted into the
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jugular vein through the bore of a suitably sized needle to a depth of 10cm and a 10ml
sample extracted.
2.4.2 Timed Ovarian vein Samples
In the 18 animals designated for follicle dissection, both utero-ovarian veins
were cannulated at the uterine branch with silastic tubing (1.6 ID x 3.2mm OD, Don
Corning, Mid Law, USA). The end of the tubing was then advanced so it lay within
the utero-ovarian vein and the uterine branch tied off with a suture. The proximal end
of the ovarian vein was then occluded and a timed 10ml blood sample taken from each
side of the tract.
2.5 Follicle Dissection and Incubation
Isolated ovaries were microdissected using sterilised forceps with each antral
follicle recovered being placed into a petri dish containing Ml99 medium (Sigma,
Dorset, UK), previously warmed to 37°C. After the dissection of all visible antral
follicles from an ovary, the diameter of each follicle was measured and recorded by
placing the petri dish onto a measuring grid under a microscope. Immediately after
measuring the follicles each individual follicle was transferred to a separate well of a
24 well culture plate, with each well containing 1ml ofM199 (37°C). The plates were
then incubated at 37°C (5% CO2) for 2 hours, after which each follicle was
transferred to a well containing a fresh 1ml of Ml99 on a new culture plate. The
incubation plates were then covered with adhesive plastic covers (Sigma) and stored
at -25°C for assay. After transfer to the new plates the follicles were hemisected
under a microscope using microscissors with half of the follicle shell fixed in 4%
paraformaldehyde, and the other half snap frozen in liquid nitrogen. The plates
containing the follicular fluids in Ml99 were immediately frozen at -25°C for assay.
2.6 Immunoassays
2.6.1 Oestradiol Assay
Oestradiol was measured using an assay method previously described (Baird, et
al., 1981) with a sheep anti-oestradiol antibody (BW 26/9/82) used at a final working
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dilution of 1:500,000 as first antibody. This assay was run using 125I labelled
oestradiol-17(3 as a tracer (in house) and ocstradiol-17(3 (Sigma) as a standard for the
assay, in the range 39-10,000 pg/ml. Sensitivity of this assay was 42 pg/ml and the
intra and inter assay coefficients of variation were 7.9% and 12.7%. The protocol for
this assay can be found in the appendix at the end of this thesis.
2.6.2 Androstenedione Assay
Androstenedione was measured in media samples using a previously described
protocol (Campbell, et al., 1990) which employs an anti-androstenedione C3
antibody (Thomson, et al, 1989) at a final working dilution of 1:3,000,000. 125I
androstenedione tracer (Donated by the University of Glasgow) and powdered
androstenedione (Sigma) as a standard for the assay with a range from 39-10,000
pg/ml. Sensitivity of this assay was 40 pg/ml and the intra and inter assay
coefficients of variation were 8.6% and 14.3%. The protocol for this assay may be
found in the appendix at the end of this thesis.
2.6.3 Progesterone Assay
Progesterone was measured in unextracted blood samples taken from the jugular
veins of the animals studied using a specific radioimmunoassay. This assay was
modified to allow the measurement of progesterone in the plasma without extraction
(McNeilly and Fraser, 1987). Buffer pH was reduced to 6.0 and 8-Anilino-l
napthaline sulphonic acid was included to prevent binding of the steroid by carrier
proteins present in the blood. The primary antibody used was a lyophilised
antiserum (SAPU S235-201) at a working dilution of 1:30,000. Standards were
generated in house from purified progesterone (Sigma, Dorset, UK), diluted in
absolute ethanol between in the range 1-120 nmol/1. The tracer used was 125I labelled
progesterone-11 a-glucuronide (Amersham Pharmacia Biotech, Bucks, UK).
Sensitivity of this assay was 0.6 nmol/1 and the intra and inter assay coefficients of
variation for three quality control pools were 6.6% and 7.6%. The protocol for this
assay may be found in the appendix at the end of this thesis.
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2.6.4 FSH Assay
The measurement of FSH in the peripheral plasma of ewes was carried out
using a specific radioimmunoassay (Campbell, et al, 1989). The primary antibody
used for FSH capture was NIDDK-NIH anti-ovine FSH-1 used at a working dilution
of 1:12000. USDA-oFSH-SIAFP-RP-2 was used as a standard (range = 0.1-25 ng/ml)
with NIAMMD oFSH-19, iodinated in house via the lactoperoxidase method, used
as a tracer. The sensitivity of this assay was 0.1 ng/ml and the intra and inter assay
coefficients of variation were 6.6% and 11.8%. The detailed protocol for this assay
can be found in the appendix of this thesis.
2.6.5 Inhibin A Assay
Levels of inhibin A were measured using a specific two-site enzyme-linked
immunosorbent assay (ELISA) developed for the measurement of the hormone in
human biological fluids (Groome, et al., 1994) and modified to detect the ovine form
of the dimer (O'Brien, et al, 1996). This protocol utilises an antibody sandwich
method with one antibody binding inhibin alpha subunit, and the other antibody
binding inhibin (3A subunit. Detection of inhibin A was carried out using an
immobilised mouse monoclonal antibody (E4 clone - N. Groome, Oxford Brookes
University, UK) targeted against the (3A subunit and a biotinylated alpha C specific
PPG monoclonal antibody. Purified 32 kDa bovine inhibin diluted in ovariectomised
(OVX) sheep plasma was used as a standard in the range 15 - 1000 pg/ml. Standards,
samples and quality controls were boiled and treated with hydrogen peroxide to
denature and oxidise the sample and allow antibody binding. The sensitivity of this
assay was 15.6 pg/ml and the intra and inter assay coefficients of variation were 3.8%
and 4.8%. The full protocol for this assay may be found in the appendix at the end of
this thesis.
2.6.6 RIA Counting and Data Reduction
The level of radiation in the assay tubes generated by the radioimmunoassays
employed in this work were counted using a Multigamma 1261 counter (Wallac,
Turku, Finland) with well-type aluminium-covered sodium iodide crystals. This
counter had a minimum efficiency of 75% for the detection of 125I. The data produced
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by the gamma counter was then interpreted using AssayZap software (Elsevier
Biosoft, Cambridge, UK) which plots standard curves and continually updates intra
and inter assay coefficients of variation for each assay protocol.
The 96-well plates used for the detection of inhibin A were interpreted using a
LabSystems Multiscan MCC/340 (Life Sciences International Ltd., Basingstoke, UK)
plate reader at a wavelength of 492 nm and the results transferred to the AssayZap
program as with the radioimmunoassay data.
2.6.7 Statistical Analysis
Statistical tests on the data generated by the work contained in this thesis were
carried out using an Apple Macintosh Computer. Student /-tests were performed
using the Analysis Toolpak plugin found in Mircosoft Excel 2001, while analysis of
variance followed by Bonferroni's post hoc analysis was carried out using XLSTAT
statistical analysis software (AddinSoft, Paris, France).
Further details of statistical tests used can be found in the experimental
chapters of this thesis (Chapters 3 - 7).
2.7 Tissue fixation and processing
2.7.1 Fixation of tissue for Paraffin Embedding
Ovarian tissue was placed into 4% paraformaldehyde (PFA) immediately
following ovariectomy. The tissue was allowed to fix in this solution for
approximately 24 hours before transfer to 70% ethanol until embedded into paraffin
wax.
2.7.2 Tissue processing and sectioning
Ovarian tissue was dehydrated by treatment with a series of alcohols prior to
the saturation of the samples with paraffin wax. This whole process was carried out
using a 17.5 hour automated protocol on a Leica TP-1050 processor (Leica UK Ltd.,
Milton Keynes, UK). The tissue was then embedded in the desired orientation in
molten paraffin wax and the wax allowed to cool prior to the sectioning of the tissue.
5pm sections of the tissue were cut using a hand-operated microtome (Jung RM2035;
Leica UK Ltd) and floated on the surface of distilled water (RNAse free for in situ
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hybridisation slides) in a water bath at 40°C. Individual sections were then positioned
onto single Superfrost microscope slides (BDH Laboratory Supplies, Dorset, UK)
and dried overnight prior to the performance of staining protocols.
2.8 Immunohistochemistry
2.8.1 Antibodies
For detection of the a-subunit, a rabbit polyclonal antibody (R150) raised
against amino acids 1-26 of the N-terminus of the porcine inhibin a-subunit
















Figure 2.1 A comparison of the amino acid sequences of the sheep inhibin subunits
with the porcine (a subunit) and human (p subunits).
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Mouse monoclonal antibodies raised against amino acids 82-114 of the PA
subunit of human inhibin (E4 clone) and amino acids 82-114 of the human pB subunit
(12/13 clone), were supplied by Professor Nigel Groome, Oxford Brookes
University, UK. The polyclonal anti-Mullerian hormone (AMH) antibody raised in
the rabbit was supplied by Dr Nathalie Josso (INSERM U493, France). Figure 2.1
shows the sequence homology between the published ovine inhibin subunit
sequences and the amino acid sequences of the porcine and human subunits against
which the antibodies employed in this work were raised.
2.8.2 Double Fluorescent Immunohistochemistry
Paraffin wax was removed from the sections by treatment with both xylene and
histoclear for five minutes prior to the rehydration of the tissue using a series of
alcohols (100 - 70%). Antigen retrieval was carried out by boiling slides in citrate
buffer for 5 minutes, after which they were washed twice in phosphate buffered
saline (PBS) for five minutes.
Slides were then treated with a blocking solution of normal goat serum diluted
1:5 in PBS for 30 minutes, before being washed as before. Primary antibodies were
diluted to the required concentrations in blocking solution and applied to the tissues,
with control slides being treated with serum from the same species the primary
antibodies were raised in.
The slides were then incubated overnight at 4°C to allow antibody binding. The
following day, slides were washed thoroughly in PBS prior to the addition of
fluorescent second antibodies (FITC anti-mouse, TRITC anti-rabbit; Sigma, Dorset,
UK). These antibodies were diluted to the working dilution of 1:50 in blocking
solution and the slides were then left in a hydrated slide box for 1 hour at room
temperature. The slides were then washed in PBS before being mounted using
aqueous Citifluor mounting solution (Citifluor Ltd., London, UK).
In order to ensure that the antigen retrieval step of this protocol and the fixative
used made no significant difference to the immunostaining pattern seen in the ovarian
sections the procedure was carried out using ovaries fixed using two preparations
commonly used in the fixing of histological tissues and with sections either subjected
to the antigen retrieval treatment or not. The results, which are summarised in Table
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2.1, show that the variations in the staining method made no difference to the staining
pattern observed using the three inhibin antibodies.
Stage of Fixative Antigen Retreival
Follicle PFA Bouin's + -
Pri - - - -
SP - - - -
a LP + + + +
Subunit SA + + + +
MA ++ + + + + ++
LA + + + + + + ++
Pri + + + +
SP + + + +
BA LP + + + +
Subunit SA + + + +
MA + + ++ ++ ++
LA + + ++ ++ ++
Pri + + + +
SP + + + +
BB LP + + ++ ++ ++
Subunit SA + + ++ ++ ++
MA + + ++ ++ ++
LA + + ++ ++ ++
Table 2.1 Effect of tissue fixative and antigen retrieval on the pattern of inhibin
subunit immunostaining in the ovine ovary. Pri - Primary; SP - Small preantral; LP -
Large Preantral; SA - Small antral; MA - Medium antral; LA - Large antral. Positive
staining is indicated by + and strong staining by ++.
2.8.3 Image Analysis
Tissue sections generated by the double fluorescent immunohistochemistry
protocol were studied using a Zeiss 510 Laser scanning confocal microscope (Zeiss)
which has the capability to detect two wavelengths of fluorescence from the same
tissue section, providing two differing fluorescent antibodies have been used for
detection. Images were captured using LSM 510 software (Zeiss), which also
provided dimensions of the selected area.
For additional image analysis, these images were transferred to an Apple
Macintosh computer and imported into Scion Image Analysis software (version
1.62c; Scion Corp., Maryland, USA). This program allows the measurement of pixel
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intensity on a scale of 1 (black) to 100 (white) across a selected area. The levels of
staining were quantified using this facet of the software to measure the average
intensity of fluorescent staining in a consistent region of cells in the tissue sections.
Levels of staining measured in the stromal tissue adjacent to follicles were
subtracted from the levels detected in follicular cells to account for non-specific
staining. The mean values for each cellular compartment within each size class of
follicle were then calculated and plotted. Image montages were created using Adobe
Photoshop 6.0 (Adobe Systems Inc., California, USA).
2.8.4 Image Analysis Validation
The method used to quantify levels of fluorescent staining in the tissues
described in this thesis is a novel protocol and therefore a form of validation was
required for this procedure to ensure low-level inter-experimental variation in the
levels of staining recorded.
To provide an indication of the variation in staining measured between slides, 8
consecutive sections were taken from one of the ovaries described in Chapter 3 of
this thesis, with all sections then subjected to the series of incubations described in
section 2.8.2 of this chapter, with an primary antibody raised against inhibin (3B
subunit. Image analysis software was then used to produce a graphical profile of the
staining detected in cross-sections of two follicles, for each of the serial sections
treated. These profiles were plotted for the 8 sections of both an early antral follicle
(Figure 2.2a) and a large antral follicle (Figure 2.2b) from the chosen ovary.
These profiles were highly comparable from one section to another indicating
a relatively low level of variation between different sections of the same follicles
using this system.
In addition, individual measurements were taken from the different cell types
in each of the follicle sections using a consistent area of interest, as described in
section 2.8.3 of this chapter. These mean pixel densities for each of these
compartments from each section of the follicles were then pooled together. The level
of staining observed in the stromal cells adjacent to the follicles in each section was
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then subtracted from the level measured in the granulosa and theca layers and the
standard error for each cell type was calculated for both follicles (Figure 2.3)
The standard errors calculated for the mean pixel densities for each
compartment in both follicles studied were very low indicating a high level of
consistency in the measurement of staining intensity in follicle compartments using
this analysis system.
Figure 2.2 Mean Immunostaining profiles for an early antral (a) and a large antral (b)
follicle incubated with an inhibin |3B subunit antibody (from 8 replicates). Each point
is shown ± SEM. (c) and (d) are representative images (from an early antral follicle
and a large antral follicle respectively) from which these profiles were recorded.
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Figure 2.3 Mean levels of inhibin (3B staining observed in the cellular compartments
of an early antral (a) and large antral (b) follicle.
2.9 Western Blotting
2.9.1 Protein Extraction and Electrophoresis
Protein was extracted from ovine ovarian structures prior to Western blotting.
The follicles and additional structures were microdissected from ovaries under sterile
conditions and immediately placed into Ml99 medium (37°C). Tissues were then
shredded individually in Falcon tubes containing 1.0 ml protein extraction buffer
using a hand held homogeniser.
Follicular fluid samples were collected directly from follicles hemisected in a
sterile petri dish and diluted in known volumes of PBS. Protein concentration was
estimated using a Genequant (Amersham Pharmacia Biotech) and for each sample at
least three measurements were made to ensure reliable readings. In addition, dilutions
of the samples were made and read in the same fashion to confirm the original
concentrations. The samples were then diluted in protein extraction buffer to give
final concentrations of 2p.g/(il. 20|il of each sample was then combined with 5|il of
5X sample application buffer containing (3-mercaptoethanol (reducing) or not (non-
reducing).
Samples were separated by electrophoresis along with prestained low range
protein markers (Bio-Rad Laboratories Ltd., Hemel Hempstead, UK) and the
resulting gel electroblotted using a wet transfer method onto PVDF membrane
(Amersham Pharmacia Biotech). After the transfer of protein to the membrane, the
gel was stained with Coomassie blue solution for 5 minutes.
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2.9.2 ECF Detection
Membranes produced by the electroblotting protocol described in the previous
section were immediately treated with blocking solution (5% normal swine serum
diluted in a Tris-buffered saline/Tween solution) for at least 1 hour at room
temperature (or alternatively overnight at 4°C). Membranes were then incubated with
primary antibodies diluted to the desired concentration in blocking solution for 1 hour
at room temperature and washed thoroughly in TBS-T prior to further incubation
with an associated alkaline phosphatase linked second antibody (diluted in blocking
solution) for 1 hour at room temperature. After another series of TBS-T washes the
membranes were transferred to square petri dishes where they were immersed in
enhanced chemifluorescence substrate (ECF; Amersham Pharmacia Biotech) in the
dark for 20 minutes. Membranes were then air-dried on a sheet of Whatman paper
(Inverclyde Biologicals Ltd., Belshill, UK) for a further 20 minutes in the dark, prior
to detection on a Storm 860 Phosphoimager (Amersham Pharmacia Biotech). Images
were then transferred to an Apple Macintosh computer and images compiled using
Adobe Photoshop 6.0.
2.10 In situ Hybridisation
2.10.1 Probe Preparation
Plasmids with inhibin subunit cDNA inserts were linearised (2.5|ll plasmid
preparation, 2jll1 specific restriction enzyme, 5|il 5X restriction enzyme buffer
(Sigma) and 40.5jll1 nuclease free water, incubated at 37°C for at least two hours). The
restriction enzymes used varied depending on the plasmid being linearised. 2p,l of the
reaction solution was then run on a 1% agarose gel together with 1 (0.1 of uncut
plasmid, in order to confirm complete cleavage of the plasmid DNA.
2.10.2 Probe labelling
Riboprobes were created by incubating lpl of linearised plasmid with:
transcription buffer (Promega UK, Southampton, UK), DTT, rRNasin (Sigma),
rNTPs,35S labelled UTP and the appropriate RNA polymerase (T3 or T7) depending
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on the plasmid used, for 60 minutes at 37°C. At this point tRNA (Sigma) and DNase
were added along with additional transcription buffer and rRNasin. lpl of each
sample was removed prior to a further 15 minute incubation at 37°C, to allow
calculation of specific activity for each probe. After incubation the samples were run
through RNase spin columns (Amersham Pharmacia Biotech) to remove
unincorporated nucleotides and a l(ll volume from each filtered sample was added to
4ml scintillation fluid and read on a [3-radiation counter. The amount of radioactivity
measured in each sample was noted and the percentage incorporation for each probe
was determined. From these data, the quantity of each probe required to give 500,000
cpm per slide was calculated.
2.10.3 Pre-hybridisation
The detailed protocol for this procedure may be found in the appendix at the
end of this thesis.
Tissue sections mounted on slides under RNase free conditions were
rehydrated by passing through an alcohol gradient (100% - 30%). The slides were
then treated with 0.85% NaCl (5 minutes) and 4% paraformaldehyde (20 minutes)
with 5 minutes washes with phosphate buffered saline (PBS) after each treatment. A
buffered solution (lOmM EDTA, 0.1M Tris) of 2(Xg/ml Proteinase K (Sigma) was
added to the slides and incubated for 7.5 minutes at 37°C. Further incubations with
4% PFA (5 minutes) and 2X SSC (2 minutes) were followed by treatment with
0.25% acetic anhydride in 0.1M triethanolamine-FlCl for 10 minutes in order to
lessen ionic charges in the tissue. The slides were then treated with 2X SSC (2
minutes), dehydrated via an alcohol gradient (60 - 100% Ethanol) and then treated
with chloroform (5 minutes) and 100% ethanol (2 minutes) prior to being left to air-
dry.
2.10.4 Hybridisation
A volume of 35S labelled probe diluted in hybridisation buffer and calculated to
contain 500,000 cpm was added to each slide and the slides incubated in a sealed
chamber humidified with 50% formamide in IX SSC. Parafilm coverslips were placed
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onto each slide to ensure complete coverage of the probe over the tissue and the
slides incubated at 55°C for 20 hours.
2.10.5 Post Hybridisation
Parafilm was removed from each slide after hybridisation and the slides rinsed
thoroughly in 2X SSC (55°C) and then treated with 20mg/ml RNaseA (Sigma) diluted
in 2X SSC at 37°C for 1 hour. A series of treatments were then carried out at 55°C
with varying concentrations of SSC, formamide and (3-mercaptoethanol. Following
these treatments the slides were dehydrated through an alcohol gradient (60 - 100%
ethanol) and allowed to air-dry.
2.10.6 In situ Development
Slides were then coated with Ilford K2 Emulsion (Ilford Ltd., Cheshire, UK)
and placed in a sealed lightproof box for at least two hours. Once thoroughly dry, the
slides were transferred to another lightproof box and exposed at 4°C for
approximately 4 weeks. The slides were developed and fixed in a darkroom by
treatment with Kodak D-19 developer (Kodak) for 2.5 minutes, a wash with purified
water for 30 seconds and HYPAM fixer for 3 minutes. Finally the slides were rinsed
with distilled water in light for 10-15 minutes before being counterstained with
haematoxylin and mounted.
Slides were examined using aNikon Eclipse E800 microscope (Nikon UK Ltd.,
London, UK) fitted with a dark field condenser and images captured using Scion
Image analysis software (Scion Corp).
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Chapter 3 - Source of Inhibin-A throughout the Ovine Oestrous
Cycle
3.1 Introduction
The ovulatory follicle is selected during the follicular phase of the ovine oestrous
cycle. The majority of the recruited antral follicles in the ovary are unable to survive
the decline in FSH, which characterises this phase of the cycle, and become atretic.
Those follicles able to generate a trophic cAMP response to both FSH and LH make
use of the increase in LH pulse frequency in the early follicular phase and avoid
atresia. Of these selected follicles the ovulatory follicle is identified as a large, highly
visualised follicle secreting a high level of oestradiol (Baird, et al., 1991).
Inhibin and oestradiol are able to inhibit selectively FSH secretion by the anterior
pituitary (Mann, et al., 1992) and levels of both of these hormones peak during the
follicular phase of the oestrous cycle. As it is the follicles themselves which feedback
to the pituitary to maintain the hormonal environment, knowledge of the follicular
origin of inhibin A is essential to our understanding of the process of follicle
selection.
Previous work, utilising a non-specific assay targeted against all alpha subunit
containing factors, and thus detecting non-bioactive as well as bioactive molecules,
has indicated the origin of inhibins to be large oestrogenic follicles, with smaller antral
follicles also secreting considerable amounts (Campbell et al., 1991; Mann, et al.,
1992). The use of a more refined enzyme-linked immunosorbent assay (ELISA)
which employs a sandwich method utilising two antibodies, specific for the a and
PA subunits has revealed peaks in plasma inhibin-A during both the follicular and
early luteal phases (Souza, et al., 1997b; Knight, et al., 1998).
Although this research examined the levels of inhibin A in the circulation during
the oestrous cycle, the source of the dimer and any shifts in production and/or
release which may occur have yet to be elucidated.
In this study we have used this specific sandwich assay to investigate the origin
of inhibin A in the ovine ovary throughout the oestrous cycle by measuring the
concentration of the hormone in peripheral (jugular) and ovarian venous blood as well
as in the follicular fluids of dissected antral follicles. In addition, the release of inhibin
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A, oestradiol and androstenedione from dissected antral follicles during a 2 hour
incubation in vitro was measured.
3.2 Methods
3.2.1 Experimental Animals
The following work was carried out on 24 Scottish Blackface ewes during the
breeding season throughout the period October to December 1998 at the Marshall
Building, University ofEdinburgh, Lothian.
Oestrous cycles were synchronised using medroxyprogesterone acetate sponges
(60 mg/sponge, Upjohn Animal Health Division, Crawley, Sussex, UK) followed by
i.m. injection of 100]LLg cloprostenol, a potent prostaglandin F2a analogue (Estrumate,
Cooper's Animal Health Ltd, Crewe, Cheshire, UK). The synchronised ewes were
then allocated to one of three groups of eight animals and underwent surgery at one
of three time points during the oestrous cycle: late follicular phase (day 1 - oestrus
+24h), mid-luteal (day 10), and early in the follicular phase (day 15 - PG +24h).
These time points for ovariectomy were selected to provide ovaries containing
follicles at different stages of development. Two animals in each group of eight were
selected for ovariectomy for the purpose of histological analysis with the other 6
animals having their ovaries removed for follicle dissection.
3.2.2 Experimental Procedure
Ovariectomy and the removal of jugular and timed ovarian vein blood samples
was carried out on all animals as previously described in Chapter 2 (2.3 - 2.4.2)
The ovaries were then removed from all animals, with both ovaries from two
animals in each group fixed for histological analysis. Ovaries from the remaining 18
sheep were microdissected and all visible antral follicles collected. Follicle diameter
was recorded (in mm) prior to each follicle being placed in an individual well of a 24
well culture plate and incubated for 2 hours in 1 ml of Medium 199 (Sigma, Poole,
Dorset, UK). Following incubation, each follicle was transferred to a well on a new
culture plate containing a fresh 1ml of M199. All follicles were hemisected using
microscissors and both sets ofmedium were frozen at-20°C, Finally, one half of the
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follicle shell was fixed in paraformaldehyde and the other half snap frozen in liquid
nitrogen.
Follicular fluid volumes were calculated by entering the diameter of each follicle
into the following equation:
volume = 0.52(diameter2 7) (Carson, et al., 1981).
3.2.3 Assays
All resulting media samples from both the incubations and the hemisections were
assayed for oestradiol, androstenedione and inhibin A. Ovarian venous blood
samples were assayed for oestradiol, progesterone, inhibin A and jugular venous
blood samples assayed for LH, inhibin A and progesterone.
Protocols for each of these assays are included in this thesis (Chapter 2 and
Appendix).
3.2.4 Analysis of Data
Follicles were classified as small (<3mm) and large (>3mm), with the large
follicles further subdivided into non-oestrogenic and oestrogenic follicles. Large,
'healthy' oestrogenic follicles were defined as having a follicular fluid concentration
of oestradiol greater than lOOng/ml, a follicular fluid oestradiol: androstenedione ratio
greater than 50, and were highly visualised. Linear relationships between venous
concentrations of hormones and hormone levels compared with follicle diameter were
assessed by regression analysis, while comparisons between levels of hormone
release and follicular fluid concentrations were carried out using analysis of variance
with post-hoc analysis by Bonferroni's test.
3.3 Results
3.3.1 Venous inhibin A measurements
Blood was collected from the jugular and both ovarian veins of each of the 18
animals selected for follicle dissection. The concentrations of inhibin A in the venous
plasma were measured and the correlation between the mean levels of the hormone in
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Figure 3.1 Relationship between inhibin A concentration in the ovarian and jugular
vein (n = 18; r = 0.782; P < 0.001).
There was a significant positive relationship between the concentrations in the
two veins (r = 0.782; P < 0.001), with the level of inhibin A found in ovarian venous
plasma being significantly higher {P = 0.005) than in peripheral blood (595 ± 69.2 vs.
281.4 ± 30.6 pg/ml). The concentration of inhibin A was consistently higher in those
veins draining an ovary containing a large estrogenic follicle than those without (P <
0.001) (Figure 3.2). Although the level of inhibin A was higher in the ovarian vein
than in the jugular when including all experimental animals, when divided into the
three stages of the cycle, the only significant difference was during the mid luteal
phase (Figure 3.3). There was no significant variation in inhibin A concentration in
either vein during the cycle, although the results suggest a decrease in inhibin A
release during the follicular phase. It is probable that the small number of
measurements for each group explains the lack of significant differences between
these time points.
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Figure 3.2 Mean ± S.E.M. inhibin A concentrations in ovarian (n = 36) and jugular (n
= 18) veins and in those veins draining an ovary containing a large oestrogenic (OE+)
follicle (n= 15) or not (n= 21). Columns with different letters differ significantly (P

















Figure 3.3 Mean ± S.E.M. concentrations of inhibin A in jugular (n = 18) and ovarian
veins (n = 36) at three stages of the oestrous cycle. Columns with different letters





















Figure 3.4 Mean ± S.E.M. concentrations of progesterone and inhibin A in ovarian
veins (n = 36) draining a corpus luteum (CL+) (n = 27) or not (CL-) (n = 9). For each




Figure 3.5 Mean ± S.E.M. concentrations of progesterone in the jugular (n = 18) and
ovarian vein (n = 36) at three stages of the oestrous cycle. Columns with different
letters differ significantly (P < 0.05, analysis of variance).
The presence of a corpus luteum (CL) in an ovary, made no difference to the
concentration of inhibin A recorded in the ovarian vein (Figure 3.4). In contrast, the
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level of progesterone in the ovarian vein was increased 500 fold by the presence of a
CL. This increase in progesterone output by an ovary containing a CL was reflected
in the level of progesterone measured in the ovarian vein during the mid luteal phase,
the stage of the cycle from which all CL-containing ovaries were obtained (Figure
3.5).
ML EF LF
Figure 3.6 Mean ± S.E.M. FSH concentrations in the jugular veins (n = 18) of ewes
at three points during the oestrous cycle. Columns with different letters differ
significantly (P < 0.05, analysis of variance).
The levels of FSH present in the circulation of the ewes studied were measured
(Figure 3.6). The concentration of FSH was significantly lower during the early
follicular phase of the cycle compared to that seen during the mid-luteal phase, with
levels of the gonadotrophin becoming comparable with mid-luteal concentrations
during the late follicular phase.
3.3.2 In vitro hormone measurements
Hormone production andfollicle size
The follicular concentrations and release in vitro of inhibin A (Figure 3.7) were
greater (P < 0.001) from large non-oestrogenic follicles (>3mm) than from small
follicles (<3mm), with both measurements being greater from large oestrogenic
follicles than from large non-oestrogenic follicles (P < 0.001). Large oestrogenic
follicles, classified by parameters relating to oestradiol production, contained more
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than double the amount of inhibin A in their follicular fluids compared to large non-
oestrogenic follicles (757 ± 109.2 vs. 315 ± 44.4 ng/ml) and released over three times

































Figure 3.7 Mean ± S.E.M. inhibin A release (A) and follicular fluid concentrations
(B) from all small (n = 488), large non-oestrogenic (n = 55) and large oestrogenic (n =
22) follicles collected. Columns with different letters differ significantly {P < 0.05,
analysis of variance).
During the classification of large follicles, a population of follicles (15 of 92 large
follicles identified) with a follicular fluid oestradiol concentration over 100 ng/ml and
an oestradiol: androstenedione ratio of less than 50 were identified. Despite their high
levels of oestradiol, these follicles released very little steroid during incubation and
were therefore classified as unhealthy, or atretic large follicles and were not included
in either the non-oestrogenic or oestrogenic groups. Although these follicles were
classified as unhealthy large follicles with respect to oestradiol production and
release, the levels of inhibin A secreted by, and present in the follicular fluids of
these follicles were comparable to those from large non-oestrogenic follicles with the
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follicles releasing an average of 15.8 ± 4.8 ng/foll/2hr and maintaining a mean follicular
fluid concentration of 475 ± 69.4 ng/ml.
Figure 3.8 Relationship between follicle diameter and the release of (A) oestradiol (n
= 580, r = 0.72, P < 0.001) and (B) inhibin A (n - 580, r = 0.52, P < 0.001,
regression analysis) during 2h in vitro incubation. The dotted line represents the
division between small and large follicles.
A significant correlation was found between the diameter of the follicle and the
release of both oestradiol (r = 0.72, P < 0.001) and inhibin A (r = 0.52, P < 0.001)
during the 2 hour incubation period (Figure 3.8).
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(A) Mid Luteal (B)
Figure 3.9 Relationship between follicle diameter and in vitro release of oestradiol
(A) and inhibin A (B) from follicles at mid-luteal (n = 220), early follicular (n = 207)
and late follicular (n = 153) stages of the cycle. The dotted lines represent the
division between small and large follicles.
Highly significant correlations (P < 0.001) between follicle diameter and the
release of both oestradiol and inhibin A were observed at all stages of the oestrous
cycle studied (Figure 3.9). In addition, it was also noted that the correlation with
inhibin A secretion was higher (r = 0.72) during the early follicular phase than at the
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Figure 3.10 Correlation between the follicular fluid concentrations of oestradiol and
inhibin A in (A) non-oestrogenic (n = 55, r = 0.43) and (B) oestrogenic follicles (n =
22, r = 0.36).
A comparison of the correlation between the follicular fluid concentrations of
oestradiol and inhibin A measured in both non-oestrogenic and oestrogenic follicles
showed no significant difference in correlation between the two follicle classes (Figure
3.10). Furthermore, the correlation between oestradiohandrostenedione ratio and
follicular fluid inhibin A concentration did not vary significantly between non-
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Figure 3.11 Relationship between the oestradiohandrostenedione ratio and inhibin
centration in the follicular fluids of large oestrogenic (n = 22), non-oestrogenic (n =
55) and follicles classified as unhealthy (n = 15).
Hormoneproduction and stage ofthe oestrous cycle
Large follicles collected during the early follicular phase released more (P =
<0.001) oestradiol than large follicles dissected from ovaries at the other stages. In
contrast inhibin A secretion by large follicles was comparable during the luteal and
early follicular phases but declined significantly (P < 0.001) during the late follicular
phase (Figure 3.12A). The concentration of oestradiol in the follicular fluid of large
follicles after a 2 hour incubation reflected the change in release of the steroid with a
significant fall (P < 0.001) in the late follicular phase. In contrast there was no change
in the concentration of inhibin A or androstenedione in the follicular fluid of large
follicles throughout the cycle (Figure 3.12B).
There was little change in the concentration of steroids or inhibin A in the
follicular fluid of small follicles during the cycle or in their release during incubation.
There was, however, a significant increase (P < 0.001) in the mean concentration of
oestradiol in the follicular fluid of small follicles collected during the follicular phase
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compared to those from the luteal phase, although this rise was not reflected in the
level of the steroid released in vitro. The release of inhibin A by small follicles peaked
(P < 0.001) during the mid luteal phase, however, there was no change in the
concentration of the hormone in the follicular fluid of these follicles.
Large oestrogenic follicles maintained higher concentrations of inhibin A in their
follicular fluid and released significantly more (P < 0.001) of the dimer than either
small follicles or large non-oestrogenic follicles during the luteal and early follicular
phase (Figure 3.13) Although the concentration of inhibin A in follicular fluid of large
oestrogenic follicles was comparable at all stages of the cycle, large oestrogenic
follicles collected during the mid luteal phase released significantly more (P < 0.001)
inhibin A than those from follicular phase ovaries. The concentration of inhibin A in
the follicular fluid and the level of release of the hormone from small follicles and large
non-oestrogenic follicles did not vary between the stages of the cycle. The
concentration of inhibin A in the follicular fluid of large non-oestrogenic follicles was
significantly higher than the level measured in small follicles during the early follicular
phase, however, the release of inhibin A by large non-oestrogenic follicles was only






































Figure 3.12 Mean ± S.E.M. release (A) and follicular fluid concentrations (B) of
inhibin A, oestradiol and androstenedione after 2h incubation in vitro from small (n =
488) and large follicles (n = 92) at three stages of the oestrous cycle. For each




































Figure 3.13 Mean ± S.E.M. inhibin A release (A) and follicular fluid concentration
(B) from small, large non-oestrogenic and large oestrogenic follicles from three stages
of the oestrous cycle. Columns with different letters differ significantly (P < 0.05,
analysis of variance).
3.4 Discussion
Our study has confirmed that the ovary secretes a large amount of inhibin A at
all stages of the oestrous cycle of the ewe. The fact that the concentration of inhibin
A is highest in the blood draining an ovary containing a large oestrogenic follicle
(Figure 3.2) strongly suggests that this follicular population is the major source of
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inhibin A secreted by the ovary. Additionally, the fact that levels of inhibin A
measured in ovarian veins draining ovaries without large oestrogenic follicles were
consistently greater than the jugular levels suggests that other structures within the
ovary secrete the hormone in addition to preovulatory follicles. The observation that
the presence of a corpus luteum makes little difference to the concentration of inhibin
A measured in the ovarian vein (Figure 3.4) is consistent with the previous suggestion
that the ovine CL does not produce inhibin (Mann, et al., 1989). However, as widely
noted in the literature (Baird, et al, 1973), the CL is a major source of progesterone in
the ovine ovary during the luteal phase of the cycle (Figure 3.5).
The concentration of inhibin A in follicular fluid is extremely high in large
oestrogenic follicles compared to large non-oestrogenic and small follicles. Large
oestrogenic follicles secrete greater amounts in vitro than follicles from the other two
classes (Figure 3.7). Although large non-oestrogenic and small follicles do not secrete
as much inhibin A as large oestrogenic follicles, they still contribute significantly to
the overall production of the hormone by the ovary. The concentration of inhibin A
in ovarian venous blood draining an ovary containing only large non-oestrogenic
follicles and small follicles is higher than that measured in jugular venous blood
(Figure 3.2).
The overall production of inhibin A in vitro is greater from large non-
oestrogenic than from small follicles. However, the fact that there are so many more
small follicles than large follicles makes it difficult to assess the relative contribution
of the two classes to the total secretion of inhibin A by the ovary.
Although there are large oestrogenic follicles present in the ovaries at each stage
of the cycle studied, oestradiol secretion by large follicles peaks during the early
follicular phase. The rise in oestradiol secretion in vivo is dependant on the
stimulation of the follicle by the marked increase in LH pulse frequency which occurs
during the luteal-follicular transition (Baird, 1978b). Each pulse of LH stimulates an
increase in the production of androstenedione by the theca cells of the follicle
(Campbell, et al, 1998a) which is then used by the granulosa compartment of the pre¬
ovulatory follicle to produce oestradiol (McNeilly, et al, 1984). The significant
increase in oestradiol release, in vitro, by large follicles dissected during the early
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follicular phase probably reflects the increase in in vivo gonadotrophin stimulation
prior to follicle collection.
There was a significant fall in the concentration of oestradiol in the follicular
fluid and in release in vitro from large follicles collected in the late follicular phase
(Figure 3.12). These ovaries were collected 24 hours after the onset of oestrus, within
a few hours of ovulation. Therefore it was assumed that these ovaries had been
exposed to the preovulatory LH surge, which occurs within 4-8 hours of the onset of
oestrus (Cumming, et al., 1973). This fall in oestradiol concentration is consistent
with the marked decline in oestradiol secretion observed at this stage of the cycle
(Baird and McNeilly, 1981).
The surge levels ofLH induce profound changes in the structure and function of
the pre-ovulatory follicle bringing about the initial stimulation and subsequent
inhibition of both androstenedione and oestradiol secretion (Baird and McNeilly,
1981). Luteinisation of the granulosa cells is initiated in anticipation of production of
progesterone by the corpus luteum. The significant decline in the follicular fluid
concentration and release in vitro of oestradiol from large follicles collected during the
late follicular phase reflects this inhibition of steroid synthesis.
The follicular fluid concentration and release in vitro of inhibin A was lower in
large follicles collected during the late follicular phase compared to those dissected
earlier in the same phase or in the luteal phase (Figure 3.12). This decrease in the
release of inhibin A is likely to reflect a loss of phenotype in large oestrogenic
follicles associated with the luteinisation of both their granulosa cells due to the
preovulatory surge of LH. This hypothesis is supported by the fact that luteal tissue
does not secrete either oestradiol or inhibin A in the ewe (Mann, et al., 1989) and also
that peripheral inhibin A (Knight, et al., 1998) and inhibin secretion (Souza, et al.,
1997b) fall during the follicular phase.
In addition to increasing steroid output by the theca and granulosa cells, the LH
surge also affects the ability of granulosa cells to produce inhibin A. Within 24 hours
of the LH surge the expression of mRNA for the inhibin a and flA subunits in
granulosa-lutein cells of the peri-ovulatory follicle is inhibited (Engelhardf et al.,
1993), although PB subunit mRNA expression persists in the mature corpus luteum.
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The exact timing of these changes is not known but it may explain the
significant fall in the secretion of inhibin A in the ewe immediately after ovulation.
Additionally, the level of inhibin A released by small antral follicles was lower
in follicular phase ovaries than from those removed during the luteal phase (Figure
3.13). This decline may reflect the high levels of atresia observed in subordinate
follicles during the follicular phase which is essential for the selection of a specified
number of ovulatory follicles.
The maximal secretion of inhibin A from large oestrogenic follicles during the
luteal phase may be due to the fact that inhibin A production, unlike oestradiol, is not
dependant on LH, but rather FSH. The synthesis of inhibin A by the granulosa cells
is stimulated by FSH (Campbell and Baird, 2001), the levels of which fall
progressively throughout the follicular phase reaching a nadir just prior to ovulation.
Therefore, the reduction in inhibin A production by large oestrogenic follicles in
the follicular phase may be attributable to the low levels of FSH released by the
pituitary at this stage of the cycle (Figure 3.6). However, the fall in inhibin A release
during the early follicular phase was not reflected in the peripheral levels of the
hormone measured. Therefore this decrease in output of the dimer by small and large
oestrogenic follicles may be due to the in vitro environment and it is possible that
follicles from the EF phase are more susceptible to the removal of gonadotrophins
and local factors present in vivo. It may also be possible that there is a structural
difference between the follicles at the two stages, which has little effect in vivo, with
those follicles during the ML stage being more permeable to inhibin A.
In conclusion, we have shown that the main source of ovarian inhibin A in the
sheep are large oestrogenic follicles with a significant quantity of the hormone
produced and released by both small antral and large non-oestrogenic follicles. In
addition, we note a decrease in the secretion of the dimer by small antral and large
oestrogenic follicles during the early follicular phase which may be attributable to the
recorded fall in FSH in the periphery at this time. It should be noted that at this point
during the follicular phase, selection of ovulatory follicles has already occurred and
therefore the fall in inhibin A secretion is likely to reflect the large number of follicles
which are in the early stages of atresia.
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Chapter 4 - Expression of inhibin subunits throughout the oestrous
cycle of the ewe
4.1 Introduction
The pituitary-derived gonadotrophins FSH and LH together form the primary
trophic stimulus for follicle growth and development in mammals. In addition to FSH
and LH, the influences of a cohort of numerous local ovarian factors in the control of
the process have also been reported. The granulosa cell-derived ovarian peptides
inhibin and activin have considerable effects on follicle development at the level of the
pituitary with inhibin acting to inhibit FSH release (Ling, et al., 1985) and locally
produced activin directly opposing this effect (Carroll, et al., 1991b).
As well as their modulation of FSH release from the brain, inhibin and activin
are able to affect the growth and differentiation ofmany cell types and their subunits
have been recorded in numerous tissues throughout the mammalian body, including
the kidneys (Kojima et al., 2001), liver (Lau et al., 2000), prostate (Mellor et al.,
2000), adrenal glands (Munro et al., 1999) and the heart (Ladd et al., 1998). Activins
are synthesized at high levels in cancerous tissues, including cancer of the prostate
(Dowling and Risbridger, 2000), ovarian epithelial tumours (Zheng et al., 2000) and
are implicated in the growth of these tumours. Activin has also been implicated as an
essential molecule in the modulation of tissue repair, with high-level expression at
sites of trauma (Hubner et al., 1999) and may in addition contribute to rheumatoid
arthritis (Gribi et al., 2001).
Inhibins on the other hand do not seem to have such a wide range of
physiological effects with the majority of their reported effects taking place in the
brain and gonads.
Studies examining the expression of inhibin subunits in the mammalian ovary
have revealed differential synthesis of the subunits depending on the stage of follicle
development. Early work concerned with the expression of inhibin subunit mRNAs
throughout the oestrous cycle of the ewe (Rodgers et al., 1989; Tisdall, et al., 1994)
detected mRNA signal for both the a and (3A subunits in only the granulosa cells of
healthy antral follicles with no changes in expression throughout the cycle. Another
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report detected (3B subunit mRNA in only the granulosa cells of healthy antral
follicles (Engelhardt, et al., 1993) along with mRNA for both the a and PA subunits,
however, in contrast to the other research discussed, inhibition of inhibin mRNA
expression was found shortly after the LH surge, concomitant with the fall in
oestradiol release by the ovarian follicles.
In each of these studies no evidence of mRNA for either subunit in ovine
corpora lutea is presented, which is consistent with previous findings suggesting that
the corpus luteum of the ewe does not secrete inhibin (Mann, et al., 1989) despite
earlier reports to the contrary (Tsonis et al., 1988). In contrast to the sheep, human
and primate corpora lutea express both a and PA subunit mRNA and protein in their
luteinised granulosa cells (Schwall et al., 1990; Smith et al., 1991; Roberts, et al.,
1993) and secrete bioactive inhibin A (Davis et al., 1987).
More recently, research concerned with the ovine ovary, measured protein for
both PA and PB subunits in the granulosa cells of follicles of all sizes, including
primordial follicles. Interestingly, mRNA for the P-subunits was only evident in
specific follicle types (McNatty, et al., 2000). Expression of mRNA for both a and
PB subunits was observed in small preantral follicles (2-4 layers of granulosa cells),
larger preantral follicles and antral follicles, with PA subunit mRNA confined to the
granulosa cells of antral follicles. Detection of a subunit protein correlated exactly
with mRNA localisation, with the subunit measured in the granulosa cells of small
preantral, large preantral and antral follicles. In contrast, both P subunit proteins were
detected in all follicle types, including primordial and primary follicles, whereas
mRNA for these proteins was not detected. These observations suggest that the P
subunit protein present in primordial and primary follicles is not synthesized by the
follicles themselves and has an origin in another ovarian compartment.
If inhibins and activins are involved in the growth and development of ovarian
follicles, variation in the expression of their subunits may be expected throughout the
ovine oestrous cycle. Previous work has examined the expression ofmRNA for the
inhibin subunits throughout the cycle but not the proteins for which they code. The
aim of this study was to detect both inhibin and activin subunit mRNA and protein
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message in ovaries removed from sheep at three time points during the 17 day
oestrous cycle.
The research described in Chapter 3 utilised a specific assay for inhibin A to
measure levels of the hormone secreted by antral follicles, however, inhibin B is not
detectable in ovine plasma or follicular fluid using a specific assay (McNeilly, 2000),
indicating that the dimer is unlikely to be produced in the ewe. Therefore this work
was carried out in order to identify any follicle populations co-expressing both a and
(3B subunit protein within their granulosa cells, suggesting the possible presence of
inhibin B.
In the course of this study diffuse staining for inhibin [1 subunits was noted in
the theca layers of follicles, therefore immunostaining for the related factor anti
Mullerian hormone (AMH) was undertaken as a validation to confirm whether this
staining was artefactual.
4.2 Materials and Methods
Materials
4.2.1 Animal Tissue
Ovaries sectioned for immunochemical detection and in situ hybridisation
were obtained from 6 Scottish Blackface ewes during the breeding season throughout
the period October to December 1998 at the Marshall Building, University of
Edinburgh, Lothian.
Oestrous cycles were synchronised using medroxyprogesterone acetate
sponges (60 mg/sponge, Upjohn Animal Health Division, Crawley, Sussex, UK)
followed by i.m. injection of lOOmg cloprostenol, a potent prostaglandin F2a
analogue (Estrumate, Cooper's Animal Health Ltd, Crewe, Cheshire, UK). The
synchronised ewes were then allocated to one of three groups of two animals and
underwent surgery at one of three time points during the oestrous cycle: 24 hours
after oestrus (day 2), mid-luteal (day 10), and early in the follicular phase (day 15).




For detection of the a-subunit, a rabbit polyclonal antibody (R150) raised
against amino acids 1-26 of the N-terminus of the porcine inhibin a-subunit
conjugated to ovalbumin (Professor A. S. McNeilly, HRSU, Edinburgh, UK) was
employed. Mouse monoclonal antibodies raised against amino acids 82-114 of the
(3A subunit of human inhibin (E4 clone) and amino acids 82-114 of the human (3B
subunit (12/13 clone), were supplied by Professor Nigel Groome, Oxford Brookes
University, UK. The polyclonal anti-Mullerian hormone (AME1) antibody raised in
the rabbit was supplied by Dr Nathalie Josso (INSERM U493, France).
Methods
4.2.3 Ovariectomy
Anaesthesia was induced by minimal quantities (200-300 mg) of a mixture of
two parts thiopentone (Intraval; RMB Animal Health Ltd, Dagenham, Essex, UK)
and one part pentobarbitone sodium (Sagatal; May and Baker Ltd, Dagenham,
Essex, UK) and maintained using halothane (1.5 - 2.5%). Mid-ventral laparotomy
was then performed and the reproductive tract exteriorised. The ovaries were
removed and fixed overnight in 4% (w/v) paraformaldehyde in PBS before being
transferred to 70% ethanol.
4.2.4 Immunohistochemistry
Ovaries were halved using a scalpel, processed for histology and embedded in
paraffin wax blocks. 5pm sections were then cut, the wax removed from the sections
using xylene and rehydrated in an ethanol gradient. The sections were incubated in a
70% methanol: 30% hydrogen peroxide solution for 30 minutes (to block any
endogenous peroxidase activity) prior to a 1 hour incubation with a 20% non-specific
serum in PBS blocking solution. Sections were then incubated with primary
antibodies, targeted against the inhibin subunits, for one hour, washed with PBS and
incubated for a further hour with the corresponding fluorescent second antibody
(Sigma). The slides were mounted with 50pl Citifluor (Citifluor Ltd, London) and the
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staining visualised using a Zeiss 510 Laser scanning confocal microscope (Carl Zeiss
Microscopy, Jena, Germany).
4.2.5 In situ Hybridisation
Pre-hvbridisation
35S labelled sense and antisense riboprobes were produced from purified
pGEMTeasy plasmids (Promega, UK) containing inhibin subunit cDNAs kindly
provided by Dr C. MacDougall, ICMB, Edinburgh, UK. Plasmids were cleaved using
specific restriction enzymes to provide inserts (Table 4.1) which were then labelled
(see appendix) using either T3 or T7 polymerases. Specific activities were calculated





pGCl a - Sense Spel T7
pGC2 a - Antisense Spel T7
pGC3 (3A - Sense Xbal T7
pGC4 (3A - Antisense Xbal T7
pINpB pB - Sense BamHI T7
pINpB PB - Antisense Sphl T3
Table 4.1 Restriction enzymes used for the preparation of sense and antisense
inhibin mRNA probes.
Ovarian tissue was fixed and sectioned as previously described (Chapter 2).
Tissue sections were rehydrated using an alcohol gradient, postfixed in 4%
paraformaldehyde (PFA) in PBS for 20 minutes, washed with PBS and then digested
with proteinase K (2|i,g/ml) in a 0.1M Tris-ElCl, lOOmM EDTA solution at 37°C.
The sections were then re-fixed in 4% PFA, immersed in 2 X SSC and then washed in
0.25% acetic anhydride in 0.1M triethanolamine-HCl. Following a further treatment




Probes were diluted in hybridisation buffer to 1 X 104 c.p.m/pl 50|ul of the
probe was added to each slide and hybridisation performed in a sealed container,
humidified with 50% formamide in 2 X SSC, for 20 hours at 55°C
Post-hybridisation
Slides were washed twice with 2 X SSC at 55°C prior to incubation with RNase
A (20pg/ml in 2 X SSC) at 37°C for 1 hour. The slides were then treated with a series
of solutions containing decreasing salt concentrations and varying quantities of (3-
mercaptoethanol and formamide (See Appendix for full details) before being
dehydrated as before. The slides were then dried at room temperature, dipped in
liquid emulsion (Kodak K2; Kodak) at 42°C, transferred to a light proof box and
exposed for three weeks. Slides were developed in a dark room for 2.5 minutes in
Kodak D-19 developer, washed for 30 seconds in water and then fixed with Hypam
fixer (ILFORD Ltd., Cheshire, UK) for 3 minutes. The developed tissue sections
were then counter-stained with haemotoxylin, dehydrated, mounted and the
hybridisation visualised under bright and dark field condensers using a Nikon Elipse
E800 microscope (Nikon UK Ltd).
4.2.6 Measurement of staining intensity
Levels of immunostaining in the experimental tissue sections were quantified
using Scion Image graphical analysis software (Scion Corp, USA). The average pixel
intensity (on a scale from black to white, with black as 0 and white as 100) within a
rectangular area was measured for each cellular compartment. Four rectangles of a
consistent size were analysed from each compartment of each individual follicle, with
a minimum of five follicles per size class. Levels of staining measured in the adjacent
stromal tissue were then subtracted from all follicular cell values as a control. Mean
values of pixel intensity for each compartment of each follicle size were then
calculated and plotted. The mean number of follicles examined for each size class at
each stage of the cycle was 6.8 ± 0.29 follicles/class. This method of measuring
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staining intensity was validated (Chapter 2 - Section 2.8.3) to ensure minimal
variation between different slides included in the same run of experiments.
4.2.7 Follicle Classification
Follicles were classified into one of six groups using a number of criteria
previously described (McNatty, et al., 2000). This system of classification focuses
on both the follicle size and the extent of the growth and proliferation of the
granulosa cells of the follicles. Each follicle studied under the microscope was





















50-100 100-200 200-300 300-<2000 2000-4000 >4000
Table 4.2 Criteria used for follicle classification on immunofluorescent slides.
4.3 Results
4.3.1 Immunohistochemistry
Staining for both (3-subunits was evident in the granulosa cells of follicles at
all stages of development, with a-subunit only detectable in the granulosa
compartment of large preantral and antral follicles (Figure 4.1). However, this pattern
was not evident in all follicles. A small number of apparently healthy follicles, at
both preantral and antral stages of development showed no staining for any subunit,
or very much reduced levels compared to those detected in other follicles. These
follicles were not specific to one time point and were noted throughout the cycle.
There were no significant differences in the levels of expression of inhibin
subunits at the three stages of the cycle (Summarised in Table 4.3), with the patterns
of expression comparable with those illustrated in Figure 4.1 in each case.
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Staae of Staae of Oestrous Cvcle
Follicle ML EF LF
Pri - - -
SP - - -
a LP * * *
Subunit SA * * *
MA * * * * * *
LA * * * * * *
Pri * * *
SP * * *
RA LP * * *
Subunit SA * * *
MA * * * * * *
LA * * * * ★ *
Pri * * *
SP * * ★
RB LP * * * * * *
Subunit SA * * * * * *
MA * * * * * *
LA * * * * * *
Table 4.3 Inhibin subunit staining in follicles at increasing stages of development at
different stages of the oestrous cycle. Pri - Primary; SP - Small preantral; LP - Large
Preantral; SA - Small antral; MA - Medium antral; LA - Large antral. Positive
staining is indicated by * and strong staining by **.
Detection of a-subunit protein was found primarily in the granulosa cells, with
low level staining measured in the theca interna of some antral follicles. Diffuse
immunostaining for both (3-subunits was also evident in the theca interna (TI) and
theca externa (TE) compartments of some large preantral follicles and a large number
of healthy antral follicles.
The presence of (3A subunit protein in the theca externa was seen in follicles
from large preantral to medium antral size, with no measurable level in large antral
follicles, particularly in those follicles expressing a high level of a-subunit.
Profiles of the levels of a and (3B immunostaining across the compartments of
a follicle (Figure 4.2) indicate a high level of staining for (3B in the theca layers relative
to the peak levels seen in the granulosa, whereas the level of a staining in the theca is
low compared to the granulosa.
Staining for (3-subunits in the thecal compartments of follicles (where present)
was confirmed by quantification, (Figure 4.3) which indicated a level of staining in the
theca cells higher than that of the stromal tissue surrounding the follicles.
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Figure 4.1 Immunostaining for inhibin alpha subunit, PA subunit and PB subunit
protein in follicles at increasing levels of development. G - granulosa; TI - theca
interna; TE - theca externa. All images are x400 magnification. Scale Bar represents
100pm.
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Figure 4.2 Immunostaining profile across the different compartments of a large antral
follicle incubated with antibodies raised against both the a and PB inhibin subunits.
The measurement of inhibin A secretion from follicles at different stages of
development (Chapter 3) has shown that healthy antral follicles are capable of
production of this particular dimer. Dual fluorescent labelling of ovary sections with
antibodies raised against both the a and pB subunit of inhibin (Figure 4.4), revealed
the expression of both proteins in the granulosa cells of antral follicles, again with a
diffuse pattern of PB staining observed in the theca layers in these follicles as well as
late preantral follicles.
In addition to the p subunit staining observed in the theca layers, a ring of very
intense binding of the primary antibody raised against the pB subunit was noted in
the area immediately surrounding the oocyte (zona pellucida) in follicles at all stages


























































Small Preantral Large Preantral Small Antral Medium Antral Large Antral
Follicle Stage
Figure 4.3 Inhibin a, (3A and (3B subunit quantification at increasing levels of follicle
development, n = 30 for each class of follicle. For each follicle group, columns with
different letters differ significantly (P < 0.05, analysis of variance).
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Examination of inhibin subunit protein expression in the ovine corpus luteum
revealed the presence of |3B subunit-containing factors (Figure 4.5). No staining was





Figure 4.5 Immunostaining for pB subunit (b) in a mid-luteal (day 10) corpus luteum
compared with control staining (a). x400 magnification. Scale Bar represents 100pm.
St - Stroma; CL - Luteal tissue.
4.3.2 In situ Hybridisation
In situ hybridisation only detected inhibin subunit mRNAs in granulosa cells,
with no staining visible in any other ovarian compartment including the theca cells.
There was no hybridisation with any of the three probes in primordial or primary
follicles at any of the time points during the cycle, with large antral follicles expressed
high levels of all three subunits (Figure 4.6).
4.3.3 AMH Immunostaining
Detection of anti-mullerian hormone was carried out in order to provide
comparative staining between the inhibin subunits and another member of the TGF-P
superfamily highly expressed in the ovine ovary. AMFI protein was seen in the
majority of follicles in the ovary at all stages of development (Figure 4.7). Its
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expression was confined to the granulosa cells only, with no staining for the protein
observed in the theca layers above that of the control sections.
4.4 Discussion
This study has employed fluorescent immunohistochemistry to detect the
expression of inhibin subunit proteins throughout the oestrous cycle, and dual
fluorescent labelling to colocalise a and (3B inhibin subunits within the ovine ovary in
order to identify follicle populations capable of inhibin B production.
Expression of inhibin a-subunit was only noted in late preantral and antral
follicles, supporting previous work inferring that antral follicles are the main source
of inhibin in the sheep (Chapter 3; Mann et al., 1992). Although preantral follicles are
unlikely to produce inhibin due to low level expression of a subunit, the observation
that small preantral follicles produce both (3A and (3B subunit protein is consistent
with the possible production of activin.
However, as previously observed (McNatty et al., 2000), (3 subunit mRNA
was not detectable in primordial or primary follicles, suggesting that the source of the
(3 subunit protein detected in these follicles lies elsewhere in the ovary. It is,
however, possible that the in situ hybridisation method used in this work was not
sensitive enough to detect low levels ofmRNA possibly present in preantral follicles.
During analysis of the (3B subunit staining, a high-level of protein was
detected in the zona pellucida (ZP) of some preantral and early antral follicles. This
staining is unlikely to be non-specific as similar patterns were not observed with the
other antibodies utilised in this study. The high-level of staining in the ZP may be
due to activin bound to activin receptors which are expressed by the oocyte in
numerous species (Izadyar, et al., 1998).
To the authors knowledge this is the first report of the presence of inhibin
subunit proteins in the theca cell layers of the ovarian follicle. The staining for (3-
subunits seen in both the theca interna, externa and in some cases several cell layers
into the stroma (Figures 4.1-4.4) indicates either the production of the proteins by
thecal cells or their diffusion from the granulosa compartment. The fact that mRNA
for both (3-subunits was only ever witnessed in the granulosa cell layers supports the
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hypothesis that activin may diffuse from the granulosa cells through the theca layers
and into the surrounding tissues. The diffusion of activin in other tissues has been
well researched (McDowell, et al., 1997; Gurdon, et al., 1999), showing that the
dimer is able to travel up to seven cell lengths through embryonic Xenopus tissue. If
this also occurs in the ovine ovary, activin may be able to act as an inter-follicular
modulator. As there was no a-subunit staining observed in the theca externa, with a
small amount seen in the theca interna of antral follicles, it may be suggested that
entities containing the a-subunit do not diffuse to the same degree as those composed
of (3-subunits and that instead they are secreted into the blood via blood vessels in
the theca externa. These observations may offer an explanation for the systemic
action of inhibin compared to the mainly local action of activin.
The fact that both a and pB subunit proteins were colocalised to the granulosa
cells of antral follicles (Figure 4.2) is consistent with the production of inhibin B by
these follicles, which produce significant levels of inhibin A (Chapter 3). However,
measurement of inhibin B in the plasma and follicular fluid of ewes is not possible
using a specific assay (McNeilly, 2000) and therefore it is unlikely that if inhibin B is
secreted by the ovary, that it is produced by the follicles.
No differences were seen in the expression of inhibin subunits at the three
stages of the oestrous cycle studied in this work. Protein synthesis of the subunits
seems to be dependant on size rather than the levels of hormones produced by the
pituitary, this may be due to the influence of local ovarian factors during periods of
decreased gonadotrophic support which are able to modulate the production of
inhibin subunits (Tekmal, et al., 1996; Bergh, et al., 1997; Webb et al., 1999).
The presence of immunostaining for (3B subunit in the ovine corpus luteum
(CL), and the distinct lack of staining for the other two inhibin subunits is consistent
with the suggestion that the ovine CL does not produce mature inhibin (Mann, et al.,
1989). However, it is possible that the luteal tissue is able to produce activin instead
of inhibin in contrast to the primate and human CL which have been shown to secrete
considerable quantities of immunoreactive inhibin (Illingworth et al., 1991). Activin
produced by the luteal tissue in the ewe may play a role in the switch in cellular
steroid production from oestradiol to progesterone induced by the surge levels of LH
and possibly be involved in the extensive angiogenesis which is characteristic of luteal
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development (Amselgruber, et al., 1999).
The pattern of expression of AMH, seen in consecutive sections to those
used for the inhibin subunit detection, supports the hypothesis that the (3-subunit
staining in the theca layers is diffusion and not an artefact. AMH, a member of the
TGF-P superfamily along with inhibins and activins, showed no evidence of diffusion
from the site of manufacture in the granulosa cells (Figure 4.7) (Bezard, et al, 1988).
However, AMH must diffuse in the fetal male to cause the degeneration of the
Mullerian ducts (Price, et al, 1977). It is possible that other members of the cohort of
TGF-P related proteins may be able to diffuse through tissue in a similar manner;
however, it is equally possible that the ovarian diffusion observed in this study is
unique to activins. One possible explanation for the apparently selective diffusion of
TGF-P proteins in the ovary is the make-up of the extracellular matrix (ECM) which
varies considerably from tissue to tissue (Kantorova, 1994). It is possible that
differences in the ECM allow the movement of certain molecules in certain tissues
whilst preventing the transport of others leading to tissue specific diffusion, such as
with AMH which diffuses in the fetal testis but not in the sheep ovary.
As to whether the effect of the diffusion of activin in the ovine ovary would
be beneficial or detrimental to nearby follicles is uncertain. However, as large antral
follicles seem to be a major source of activin, the protein may serve as an additional
negative influence on the further recruitment of smaller follicles until the large follicles
have either undergone atresia or ovulated, at which point the recruitment of another
cohort of antral follicles is necessary. This hypothesis is supported by research in
the rat showing that activin secreted by secondary follicles causes preantral follicles
to remain quiescent in vitro (Mizunuma et al., 1999).
In conclusion, this work has shown that there is differential expression of
inhibin P subunit protein and mRNA in preantral follicles. The immunohistochemical
staining has also detected diffuse P subunit staining but not mRNA expression in the
theca cell layers of late preantral and antral follicles. It is hypothesized that activin,
derived from these follicle populations acts as an intra-ovarian factor to modulate the
growth and differentiation of subordinate follicles.
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Figure 4.6 In situ hybridisation for inhibin f5A (b), |3B (d) and a-subunit (f) mRNAs
in a large antral follicle (>3mm). Haemotoxylin stained section (a) and sense controls
(c, e). xlOO. An - Antrum; G - Granulosa; TI - Theca Interna; TE - Theca Externa;
St - Stroma.
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Figure 4.7 Immunostaining for AMH in large preantral (b), early antral (d) and
medium antral (f) follicles, (a), (c) and (e) are control sections. S - Stroma; TE -
Theca externa; TI - Theca interna; G - Granulosa; AN - Antrum; Oo - Oocyte. Scale
Bar represents 100pm.
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Chapter 5 - Forms of inhibins and activins synthesized by the ovine
ovary
5.1 Introduction
Two types of inhibin (A and B) have been identified in a number of mammalian
species. Although specific assays have been developed to measure both hormones in
the human and the rat (Baly et al., 1993; Fahy et al., 1995; Groome, et al., 1996;
Robertson, et al., 1997), so far only inhibin A is measurable in the sheep, using a
modified version of the assay developed for human samples.
In human plasma, inhibin B peaks in the early follicular phase in contrast to
inhibin A, which is low at this time. Concentrations then fall gradually during the
follicular phase before peaking again shortly after ovulation and then declining for the
rest of the luteal phase (Groome, et al., 1996). The human corpus luteum, which
secretes a considerable quantity of inhibin A (Illingworth, et al., 1991), does not
release inhibin B into the circulation (Illingworth et al., 1996a). In addition,
measurement of both forms of inhibin in human follicular fluid revealed
concentrations of inhibin B 20-200 fold greater than those of inhibin A (Groome, et
al., 1996).
Research carried out using isolated rat granulosa cells has demonstrated the
differential modulation of inhibin A and B production by steroids, gonadotrophins
and local ovarian growth factors (Lanuza, et al., 1999). Both FSH and IGF-1 alone
stimulated the secretion of both inhibins with the release of inhibin A notably more
responsive to FSH, and oestradiol only stimulating inhibin A production. In addition
TGF-p brought about a considerable increase in the production of inhibin B that was
three times that of inhibin A. This dual control of production supports the notion
that the two forms of inhibin have a greater functional significance at differing stages
of the oestrous cycle in rats and humans.
In addition to the measurement of inhibin B in the female, the hormone has also
been detected in males of several species. In the human male, inhibin B is the
predominant form in terms of the suppression of FSH, with inhibin A undetectable
(Illingworth et al., 1996b; Anderson et al., 1997). An identical situation has been
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shown in the rat (Woodruff et al., 1996) where inhibin A is absent from the serum
and inhibin B is the sole isoform of the hormone. In contrast, recent research has
shown that the ram produces only inhibin A and not inhibin B (McNeilly, 2000).
These experiments demonstrate a significant sexual difference in the forms of inhibin
produced, with female mammals seemingly synthesizing both hormones and the
males only producing one.
In addition to the two forms of'mature' inhibin (32 kDa) there are a number of
other isoforms of the precursor proteins which have been identified in several
species. In the human a range of bioactive forms have been identified with molecular
weights from 30 - 120 kDa (Robertson et al., 1995), along with bio-inactive forms,
26 and 32 kDa in weight. In the cow, molecular weight inhibins of between 32 and
105 kDa have been detected (Sugino, et al., 1992). Amino acid analysis of these
proteins suggested that the 105 kDa protein is cleaved sequentially to finally give rise
to the 32 kDa, or mature form of the hormone. The fact that these reports suggest
that a number of the various forms of inhibins and activins identified (along with the
mature forms of the proteins) have a significant biological activity, implicates them in
the possible local control of folliculogenesis.
In chapter 4 it was shown that mRNA and immunoactive protein for inhibin
a, (3A and |3B subunits were present in the granulosa cells of follicles in the sheep
ovary. However, to date inhibin B has not been detected (using a specific enzyme-
linked immunosorbent assay) in the peripheral blood or follicular fluid of the ewe
(Knight, etal., 1998; McNeilly, 2000).
A number of forms of inhibins and activins have been identified in the human
(Robertson, et al., 1995), pig (Guthrie et al., 1997) and cow (Sugino, et al., 1992).
The aim of this work was to determine the types of inhibin and activin produced and
secreted by the ovine ovary.
5.2 Materials and Methods
Ovine follicular fluids and follicle shells were analysed utilising Western
blotting, in an attempt to identify whether the ewe produces inhibin B and if it does,
whether it is secreted into the follicular fluid. We have detected different molecular
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weight varieties of inhibin and activin subunits present in sheep follicles, employing
the antibodies used in Chapter 4 of this thesis, in an attempt to describe the staining
visualised by immunohistochemistry in the ovine ovary. Human follicular fluid
(HFF) samples, which are known to contain significant levels of both inhibin A and
inhibin B, were included on each Western gel in order to provide a positive control for
the detection of inhibin B.
Materials
Ovarian ovine follicles used for this study were 1) large antral follicles
(>4mm) collected from the ovaries of sheep slaughtered in an abattoir; 2) a range of
follicles, luteinised follicles and corpora lutea (mid-cycle) collected from the ovaries
of Scottish Blackface ewes in the breeding season (see Chapter 3); and 3) follicular
fluid collected from the first flush of large antral human follicles collected from in
vitro fertilization cycles as a positive control for inhibin-B (IVF Unit, Simpson's
Maternity Hospital, Edinburgh, UK).
Methods
5.2.1 Ovariectomy and Follicle dissection
Anaesthesia was induced by minimal quantities (200-300 mg) of a mixture of
two parts thiopentone (Intraval; RMB Animal Health Ltd, Dagenham, Essex, UK)
and one part pentobarbitone sodium (Sagatal; May and Baker Ltd, Dagenham,
Essex, UK) and maintained using halothane (1.5 - 2.5%). Mid-ventral laparotomy
was then performed and the reproductive tract exteriorised.
The ovaries were then removed and both ovaries from two animals in each
group were fixed for histological analysis. Ovaries from the remaining 18 sheep were
microdissected and all visible antral follicles collected. Follicle diameter was recorded
(in mm) prior to each follicle being placed in an individual well of a 24 well culture
plate in 1 ml of Medium 199 (Sigma, Poole, Dorset, UK) and hemisected using
microscissors. Finally, one half of the follicle shell was fixed in paraformaldehyde and
the other half snap frozen in liquid nitrogen.
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5.2.2 Primary antibodies
Immunochemical detection from the western blots was carried out using a
rabbit polyclonal antibody raised against porcine inhibin a-subunit (Professor A. S.
McNeilly, Human Reproductive Sciences Unit, Edinburgh, UK) along with mouse
monoclonal antibodies raised against (3A subunit (E4 clone) and (3B subunit (12/13
clone) (Professor N. Groome, Oxford Brookes University, UK). Additionally, a
mouse monoclonal antibody raised against the Pro-(3A subunit of inhibin was also
used for protein detection (A. Tsigos, Oxford Brookes University, UK).
5.2.3 Western Blot (Please see appendix for detailed protocol)
Tissues were homogenised in protein extraction buffer (20mM Tris-HCl,
150mM NaCl and protease inhibitor cocktail - Boehringer Mannheim). The
concentration of protein in undiluted and 1:10 diluted samples was measured at least
three times using a Genequant Pro (Amersham Pharmacia Biotech) and the
homogenate concentration adjusted with extraction buffer to provide a protein
concentration of lmg/ml. 20pl of each sample was mixed with 5pi of sample
application buffer with P-mercaptoethanol present (reducing) or absent (non-
reducing). Samples were loaded onto 15 well 4 - 20% tris-glycine gels (Novex) and
separated at 120V, 26mA for 2 hours. Electrophoresed proteins were transferred to
polyvinylidene fluoride (PVDF) membranes in transfer buffer (192mM Glycine,
25mM Tris Base, 20% Methanol and 0.1% SDS) at 30V, 400mA for 2 hours. Gels
were stained with Coomassie blue solution for 5 minutes. Membranes were blocked
with 5% porcine serum in TBS-T (50 mM Tris-HCl, 150mM NaCl, 0.05% Tween,
pH 8.0) for one hour and incubated with primary antibody (1:1000 dilution in
blocking solution) overnight at 4°C. After repeated washing with TBS-T the
membranes were incubated with alkaline phosphatase-conjugated anti-mouse or anti-
rabbit IgGs for one hour at room temperature. After further washes with TBS-T, the
membrane was coated with enhanced chemifluorescence (ECF) alkaline phosphatase




The Western blots presented in this Chapter are in each case representative of a
number of gels on which identical samples have been run out under the same
conditions with the same bands consistently detectable with specific inhibin
antibodies.
5.3.1 Inhibin subunit isoforms in the cells of additional ovarian structures
In order to investigate whether inhibin B is present in the ovine ovary, Western
blot analysis was carried out using a number of different tissues collected from
ovaries supplied by a local abattoir, including a range of antral follicles, corpora lutea
(CL) and luteinised follicles (Figure 5.1).
Utilising an antibody raised against mature inhibin a subunit, a number of
bands from 95 to >200 kDa were detected under non-reducing conditions in the
follicle shells (granulosa and theca cells) of large (>4mm) follicles, together with
another series of bands between 40 and 47 kDa. Reduction of these samples
produced bands of 25, 31 (only in >4mm), 35, 42 and 47 kDa in follicle shells from
all healthy follicles, with the intensity of the bands increasing with follicular size.
Detection with a (3A-subunit antibody revealed a pattern of bands in large
follicles similar to that detected with the a subunit antibody. In non-reducing
conditions bands of >90 and 46 kDa were observed with reduction of these proteins
leading to bands of 38, 42 and 49kDa. Incubation of the same blot with an antibody
raised against the (3B subunit again produced a range of protein bands comparable
with those containing the mature a subunit sequence. Prior to reduction, proteins
with molecular weights of >95 and 46kDa were detected in large antral follicles and
addition of (3-mercaptoethanol to the protein extracts produced bands of 36, 38, 42,
and 49kDa.
Human follicular fluid, included as a positive control for both inhibin A and B,
contained a subunit related proteins of 70 - >110 kDa which were cleaved to produce
31 and 49 kDa bands in addition to the original 70 - >110 kDa entities. The same
samples contained PA-associated proteins of 29, 47 and 90 kDa in non-reducing
conditions which were unaffected by reduction. Also present in HFF were two non-
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<2 2-4 >4 >4 CL LUT HFF <2 2-4 >4 >4 CL LUT HFF
Figure 5.1 Immunodetection of inhibin subunit-associated molecules in a range of
ovarian structures. CL - corpus luteum\ LUT - Luteinised follicle; HFF - human
follicular fluid. (<2, 2-4, >4 - follicle diameter in mm). Protein marker weights; 21 -
110 kDa.
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5.3.2 Inhibin subunit isoforms in the shells of large follicles
In order to examine further those (3B associated proteins observed in large
antral follicles, and in an attempt to gain further evidence for the presence of inhibin-
B in the cells of these follicles, a Western blot was performed on follicle shells
collected from a number of large ovine antral follicles (>4mm) dissected from abattoir
ovaries (Figure 5.2).
When the blot was incubated with an antibody raised against the a-subunit, a
clear band of 46 kDa together with a series of bands between 76 and >110 kDa were
seen in non-reduced samples. When these samples were reduced, a number of new
bands were observed due to the cleavage of any disulphide bonds linking protein
molecules. Proteins with molecular weights of 26, 38 (only present in follicles 1 and
5), 45 and 49 kDa were observed in these reduced samples.
Incubating the same blot with an antibody raised against inhibin (3B subunit
revealed faint bands of 44 and 52 kDa in weight prior to reduction and 44 and 50 kDa
in reduced samples.
Bands present in the HFF were not as clear as those observed in previous
blots, however, a-subunit associated proteins of >90 kDa were observed in non-
reducing conditions, with proteins of 28, 47 and >90 being detected in reduced
samples. 90 and 115 kDa (3B-associated proteins were observed in non-reducing
conditions in HFF, with proteins of 30, 34, 45 and 90 kDa being produced upon
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Figure 5.2 Detection of inhibin a and |3B subunit-associated molecules in the
follicular cells of large (>4mm) ovine antral follicles. F1 -6 - ovine follicle shells; HF -
human follicular fluid. Protein marker weights; 21-110 kDa.
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5.3.3 Inhibin subunit isoforms in ovine follicular fluid
Western blotting of follicle shell samples gives an indication of those subunit
forms produced by the cells of the follicle. In order to investigate the inhibin-related
proteins secreted by the cells into the follicular fluid, Western blots were carried out
using follicular fluid samples collected from large antral follicles (Figure 5.2) supplied
by a local abattoir and previously described in this Chapter (Section 5.3.2).
Detection of a-subunit associated molecules in these follicular fluids (Figure
5.4) revealed a collection of bands greater than 100 kDa in weight, along with a
strongly stained 45 kDa band. The addition of a reducing agent produced three bands
of 22, 45 and 49 kDa. Incubation with the (3A antibody detected non-reduced
proteins of -16, 27, 32, 42, 49-60 and >110 kDa in ovine follicular fluid. Reduction
of these samples seemed to increase the intensity of the 49 kDa band, however, the
lighter 16-42 kDa bands were not detected in the reduced samples.
There were no [IB-associated proteins detected in either non-reducing or
reducing conditions in ovine follicular fluid. In contrast, HFF contained a range of
bands >100 kDa which were immunoreactive with all three inhibin subunit
antibodies. When these samples were reduced, a 90 kDa protein was detected with all
three antibodies. This band was considerably lighter when detected with the a-
subunit antibody, and a range of bands from 50 - >110 kDa were observed. In
addition to the 90 kDa band, both P-subunit antibodies detected proteins of 31 and
33 kDa, with the pA antibody also revealing a 50 kDa band.
Along with the detection of molecules containing the protein sequence found
in the three mature inhibin subunits, another antibody raised against the Pro-[3A
subunit was employed in an attempt to define which forms of the PA subunit have
been detected. This antibody does not bind to mature PA subunit or mature inhibin
A.
Incubation with this antibody detected bands of 33, 43, 46, 55, 90 and >110
kDa (Figure 5.5). Addition of P-mercaptoethanol to the samples gave rise to bands of
34 and 48 kDa. In contrast, there were no clear bands evident in HFF in either non-
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Figure 5.4 Detection of inhibin Pro-(3A associated molecules in follicular fluid from
large ovine (F2, F6) and large human (HF) antral follicles. NR - Non-reduced; R -





Figure 5.5 Immunodetection of inhibin (IB-subunit associated molecules in luteal
tissues. CL - corpus luteum. Protein marker weights; 19-107 kDa.
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A faint band of approximately 40 kDa was visible in the mid-cycle CL (Figure
5.1), and in order to clarity this protein another blot was performed (Figure 5.5),
revealing a clear band of 42 kDa with additional bands >107 kDa.
5.4 Discussion
Healthy ovine antral follicles have been shown to produce and secrete
immunoreactive inhibin A (Chapter 3) and as expected express both a and [3A
subunits in their granulosa cells. The granulosa cells of these follicles also express a
large amount of [3B subunit protein (Chapter 4) which is required for the production
of both activin (B and AB forms) and inhibin B. In addition, the granulosa cells of
most antral follicles also express mRNA for a, (3A and pB subunit with PB staining
almost always present in large healthy follicles (Engelhardt, et al., 1993).
Therefore, the main aim of this study was to attempt to discover whether
ovine follicles, or other ovarian structures produce inhibin B.
Proteins of 46 and >90 kDa containing the mature a and PB subunit
sequences were identified in the granulosa/theca cells of antral follicles (Figure 5.1).
These bands are compatible with the production of inhibin B forms by the ovine
ovary. However, the weights of these proteins are consistent with inhibin B
precursor dimers (>45 kDa) and not the mature form of the heterodimer (-32 kDa).
In addition to the mature 32 kDa form of inhibin A, non-cleavable forms of inhibin A
precursor proteins are capable of suppressing FSH secretion in a rat pituitary cell
bioassay (Mason, et al., 1996). Therefore, if high molecular weight forms of inhibin B
exhibit this bioactivity, and are present in the ovary, it is possible that they may
exert some form of local autocrine or paracrine effect. Furthermore, recent research
has shown that levels of certain high molecular weight forms of inhibin A may be
more responsive to FSH than others (Boudjemaa, et al, 2000), suggesting possible
differential control ofmolecular weight forms of inhibin within the ovary.
If inhibin B produced by the follicle cells has a systemic role in the ewe, the
presence of the hormone in the follicular fluid of ovarian follicles would be expected,
as with inhibin A (Chapter 3). This hypothesis is supported by the fact that high
levels of inhibin B are found in human follicular fluid with levels 20- to 200- fold
greater than inhibin A (Groome, et al., 1996). Examination of Western blots carried
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out using follicular fluids from large antral follicles (Figure 5.3) revealed no (IB
subunit-associated proteins in the follicular fluid of ovine follicles. This was in
striking contrast to the numerous a and [3A containing proteins detected in the same
samples. In addition, (3B subunit bands (along with a and (3A) were observed in
human follicular fluid, included as a positive control for inhibin B. It is unlikely that
the lack of [IB detection in ovine follicular fluid is due to a technical factor as the
antibody used specifically detects the subunit in the human and also specifically
detects an ovine protein using histochemical methods (Chapter 4). Given the very
high level of homology between the (3B subunits of the human, sheep and other
mammalian species it is highly unlikely that the antibody used is non-specific and
these data therefore provide evidence that inhibin B forms are not secreted into the
follicular fluid of large ovine antral follicles by the follicular cells. Furthermore, the
lack of any proteins detectable with an anti-(3B subunit antibody in ovine follicular
fluid, suggests that activin forms containing (3B subunit are not secreted by follicles
of this size. This hypothesis contradicts the detection of high levels of activin AB in
ovine follicular fluid by a specific two-site ELISA (Evans, et al, 1997).
The follicular fluids of smaller antral follicles were not examined in this study,
as blotting and immunodetection of their follicle shells revealed lower levels of the [IB
associated proteins compared to large antral follicles. As the cells of the follicle are
assumed to be the site of manufacture of inhibin subunits, the follicular fluids of large
antral follicles were selected as the most likely source of any secreted inhibin B.
When the pattern of non-reduced and reduced bands observed in the follicular
fluid of the ewe is compared to inhibin forms identified in other species, there are a
number of parallels between the proteins detected. In both bovine and porcine
follicular fluid an a subunit containing band of -46 kDa is present along with a range
of bands >60 kDa (Guthrie, et al., 1997). After treatment with a reducing agent,
proteins of 23, 47 and 59 kDa were detected in both species. These bands may well
be consistent with the non-reduced 45 and >90 kDa, and reduced 22, 45 and 49 kDa
bands observed in this study. The fact that additional non-reduced bands of 27 and
32 kDa together with a reduced band of 29 kDa were present in the cow and pig, but
not the ewe, may reflect their absence in ovine follicular fluid or possibly a reduced
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level of protein purification in this study. However, these observations do suggest
the presence of a number of inhibin subunit/dimer forms with comparable molecular
weights in a number of species.
A faint (SB protein of ~40 kDa was evident in the CL (Figure 5.1) and a
further blot with non-reduced CL samples (Figure 5.5) revealed a more visible |3B-
containing protein of 42 kDa and additional high molecular weight bands (>107 kDa).
These proteins are likely to represent the staining observed in the CL in Chapter 4 of
this thesis.
These findings are surprising because the mature ovine corpus luteum does
not secrete immunoactive inhibin (Mann, et al, 1989; Bramley, et al, 1992) and does
not express mRNA for a, (3A or (3B subunit (Engelhardt, et al., 1993; Tisdall, et al.,
1994). However, mRNAs for inhibin a and (3A subunit have been observed in luteal
tissue shortly after ovulation (Engelhardt, et al., 1993) with the level of expression
becoming undetectable as the CL matures. The CL samples were included in the
present study as negative control tissue as the expression of any inhibin subunits had
not been observed previously. The fact that mRNA for (3B subunit is not expressed
in the sheep CL, and (IB-associated proteins have been detected in this tissue, is
consistent with the hypothesis that the origin of these proteins lies elsewhere in the
ovary, possibly neighbouring antral follicles. It may, however, be possible that the in
situ hybridisation protocol used for this research was less sensitive than the
immunocytochemical method and thus low levels of mRNA may have remained
undetected.
Furthermore, in reduced follicular shell samples, a 36 kDa (©-associated
protein remained unchanged throughout follicular development but seemed to be
increased considerably in the luteinised follicle and then further increased in the CL.
In contrast a reduced 42 kDa protein was increased during follicular development and
hardly detectable in the CL. These observations may signify a switch in the
processing of the [3B subunit during the process ofCL development
It is possible that bands detected with molecular weights of >65 kDa in both
the follicle shells and follicular fluids of both species studied are a mixture of both
precursor dimers constituting high molecular weight inhibin and activin forms, along
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with various forms of inhibin and activin bound to follistatin (FS). These complexes
have been identified in the human and have molecular weights between 66 and >220
kDa (FS-inhibin) and in the case of a FS-activin complex, a weight of around 97 kDa
(Wang, et al., 1999).
Intensities of bands seen in ovine follicles were greater in large antral follicles
than those in small follicles, possibly reflecting the predicted increase in the
production of inhibin subunits with follicle size (Chapter 3 and 4).
Finally, the presence of pB staining observed in the corpus luteum (Chapter
4) along with the detection of pB subunit (and not a or (3A) containing proteins in
CL tissue via Western blotting, indicates the possible production of activin B by
ovine luteal tissue. However, as mRNA for pB subunit has not been observed in the
ovine CL it is likely that these proteins are the product of other ovarian structures,
possibly suggesting paracrine interactions between follicles and the CL.
In summary, these findings, which demonstrate the existence of protein bands
binding both a and [IB subunit antibodies, are compatible with the presence of
inhibin B dimers in follicular cells. However there is a possibility that rather than a
band being one distinct protein, it may be several of comparable weights, in this case
possibly an activin precursor and a form of a subunit, and not an inhibin dimer.
Additionally, this research provides evidence that (3B subunit proteins are not
secreted into the follicular fluid and it is possible that the (3B proteins detected in the
follicle shells represent a percentage of the diffused pB staining observed in the theca
cell layers in Chapter 4 of this thesis.
To conclude, this work suggests that the subunits required for the production
of inhibin B are present in the follicular cells of ovine antral follicles, and more
significantly that proteins present in the granulosa/theca cells contain forms of both a
and PB subunits, suggesting the presence of inhibin B dimers. However, the absence
of PB subunit proteins in the follicular fluid suggest that if inhibin B protein is
produced by granulosa cells it is not secreted into follicular fluid.
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Chapter 6 - Effect of the FecB gene on the expression of inhibin
subunits during follicular development
6.1 Introduction
In order to investigate further the role of inhibins and activins in folliculogenesis
in the ewe, it is useful to examine breeds of sheep which exhibit an increased
ovulation rate, as these animals are likely to show variations in the levels of certain
factors involved in the control of follicles development (Baird and Campbell 1998).
An example of such a population are sheep carrying the fecundity gene (Fee8)
which have an increased ovulation rate compared to non-carrier animals. Over the
years numerous studies have recorded differences in sheep carrying this gene with
respect to factors known to influence the process of folliculogenesis. These include a
reported increase in the level of FSH and LH in the peripheral circulation of carrier
animals (McNatty and Henderson, 1987; Later contradicted by Souza, et al., 1997b),
decreased incidence of follicular atresia (Mandiki, et al., 2000) and decreased IGFBPs
in antral follicles of Fee8 animals leading to an increase in bioavailable IGF
(Monniaux, et al., 2000).
Although the gene responsible for the phenotype witnessed in these animals has
been identified, the factor for which the gene codes has remained elusive until recent
work identified a mutation in a specific receptor in these animals (Souza, et al., 2001;
Wilson, et al., 2001; Mulsant, et al., 2001) The nature of this mutation is discussed in
detail in Chapter One of this thesis.
The effect of the Fee8 gene is widespread in the context of follicular
development, with elements affected at many different stages of the process.
However, as yet, the subunit expression of inhibin and activin, factors known to
influence FSH release from the pituitary and thus follicle growth, has not been
researched in these animals.
Measurement of inhibin A in the plasma of carrier and non-carrier ewes
shows no difference between the secretion rate of the hormone into the circulation, as
well as comparable levels of progesterone, androstenedione and oestradiol between
genotypes (Souza, et al., 1997b). Furthermore, the highest amounts of inhibin
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produced by granulosa cells isolated from both genotypes are comparable, and are
derived from large, healthy follicles in both groups of animals (Henderson et al.,
1991). Although the Fee8 mutation does not seem to reduce the level of inhibin or
oestradiol feedback to the pituitary, which would increase FSH release, differences in
inhibin and activin expression may play a role within the ovaries of these animals.
Additional studies have suggested that although the level of inhibin in the circulation
is not significantly different in Fee8 ewes, the stability of the mRNA coding for the
PA subunit is increased in these animals, possibly increasing local inhibin A/activin
production in the ovary (Fleming et al., 1992).
The aim of this work was to examine the expression of the three inhibin
subunits a, PA and PB in the ovaries of Booroola animals carrying the Fee8 gene and
to compare the patterns of expression with non-carrier ewes in an attempt to identify
any role these proteins might have in the premature development of ovulatory
follicles in these sheep.
6.2 Materials and Methods
6.2.1 Ovarian Tissue
Ovaries were removed during the breeding season from 6 homozygous
wildtype (++) and 5 homozygous FF (FecB gene) 22 month old, Scottish Blackface
Merino cross ewes, in which the genotype was determined by pedigree (Haley,
1990). For each animal one ovary was microdissected as part of an unrelated study
and the other was fixed overnight in 4% paraformaldehyde before being embedded in
paraffin wax and sectioned as described in Section 2.7 of this thesis. Sections of the
tissue were then taken at a thickness of 5pm and transferred to individual slides prior
to immunohistochemistry. It should be noted that the fact that only one ovary per
animal was fixed for this work may explain the low number of antral follicles
observed in total in these animals.
6.2.2 Primary Antibodies
The antibodies targeted against the a, pA and pB subunits of inhibin used in
this study are as previously described in Chapter 4 of this thesis.
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6.2.3 Immunohistochemistry
Tissue sections from animals of both genotypes were incubated under identical
conditions, in the same run of slides, using the same preparations of antibodies for
both ++ and FF tissue. The immunohistochemistry protocol is identical to that
described in Chapter 4 of this thesis.
6.2.4 Statistical Analysis
Measurement of staining intensity was recorded using Scion Image analysis
software (Scion Corp, USA) using the method of observation described earlier in this
thesis (Chapter 2). This method of measuring staining intensity was validated as
described in section 2.8.3 of this thesis. Differences in levels of staining between
genotypes were identified using a standard two-tail /-test. The mean number of
follicles examined was 8.6 ± 0.7 follicles/class for the wildtype animals and 8.2 ± 0.9
follicles/class for the Booroola ewes. Follicles were grouped using the classification
system described in section 4.2.7 of this thesis.
6.3 Results
As observed previously in this thesis (Chapter 4), the pattern of inhibin
subunit expression was closely associated with follicle development. Proteins
containing a-subunit were found in the granulosa cells of late preantral and antral
follicles with both (3 subunits present in the granulosa compartment of follicles at all
stages of development. In addition, (3-subunit staining was evident in the theca cell
layer of late preantral and early antral follicles in both groups of animals.
In general the levels of inhibin subunit staining measured were comparable
between the two genotypes studied, however, a number of significant difference were
noted between the two groups of animals.
The levels of a subunit protein in the granulosa cells of medium sized antral
follicles were significantly lower (P <0.01) in FF animals than those seen in the non-
carrier ewes (Figure 6.1). It should be noted that this was the only difference in the
level of a subunit seen between the two genotypes in follicles of a comparable size
(Figure 6.3 - a, b).
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The pattern of staining recorded for (3A subunit protein in granulosa cells was
very similar to that observed for the a subunit, with the levels of staining only
significantly lower (P <0.05) in the FF ovaries in medium sized antral follicles than
those from ++ animals (Figure 6.3 - c, d).
However, this pattern was not evident when detecting (3B subunit, with the
only difference between the two groups of animals being an increased level (P =
<0.05) of the protein in the granulosa cells of late preantral follicles from FF ewes,
compared to the non-carrier group.
Examination of the subunit staining seen in the theca cell layers also revealed a
number of differences between the two groups (Figure 6.2). The low level of a
subunit staining seen in the granulosa cells of medium sized antral follicles was
mirrored in the theca layer, where a lower level (P <0.05) was also observed in the FF
ovaries.
In contrast to the difference seen in the (3A subunit staining in the granulosa
cells, there were no significant variations in the expression of this protein in the theca
cell layers.
Although there were no significant differences recorded in antral follicles
between the two genotypes, with respect to (3B subunit protein, levels were
significantly higher in the theca cells of both medium and large antral follicles in the
FF animals compared to those in the ++ group (Figure 6.3 - e, I).
6.4 Discussion
The phenotype of ewes homozygous for the Fee8 gene is an increased
ovulation rate due to precocious development of ovulatory follicles. As previously
discussed, this has been attributed to variations in a number of factors relating to
folliculogenesis. Although the mutation of the BMP receptor type IB has recently
been reported as the origin of the genotype (Souza, et al., 2001; Wilson, et al., 2001),
the molecular mechanisms involved in the early development of ovulatory follicles in
these animals is not fully understood.
Recent research strongly suggests that the mutated gene in FF animals
influences ovarian rather than pituitary function. When animals were rendered
hypogonadotrophic by the administration of GnRH antagonist, subsequent infusion
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of physiological amounts of FSH and LH caused no reduction in the ovulation rate,
indicating that increased FSH levels are not required for the precocious maturation
seen in these animals and that the FecB gene acts at the level of the ovary (Campbell,
etal., 1996b).
The fact that medium sized antral follicles express lower levels of both the a
and (3A subunits in FF animals compared to ++ ewes may lead to a decrease in the
production of inhibin A, or indeed activin A, by these follicles. This hypothesis is
supported by the fact that a-subunit was also lower in the theca interna cells of
medium antral follicles reflecting a decrease in the diffusion of the protein from the
granulosa cells and thus production in general. This suspected decrease in inhibin A
production from medium antral follicles in carrier animals may not be detectable in
the circulation when compared to ++ animals, as although this class of follicle may
produce less inhibin A there are a greater number of them in the ovaries of carrier
ewes, so the total ovarian secretion of the hormone is comparable.
In contrast to these findings, previous research examining the expression of
inhibin subunit mRNAs in the ovaries of FecB carrier and non-carrier ewes, has
shown increased levels of both aromatase and inhibin (3A subunit mRNA in medium
antral follicles (Campbell et al., 1998b). These observations concur with the
precocious maturation of ovulatory follicles in this species, with medium antral
follicles having increased levels of the proteins required for oestradiol and inhibin A
production, characteristic of larger antral follicles in non-carrier ewes. Therefore, the
decreased level of a and pA subunit protein seen in medium antral follicles in carriers
of the FecB gene may be due to increased release of the subunits into the follicular
fluid or the blood.
The granulosa cells of late preantral follicles had greater levels of PB subunit in
FF animals than wildtype animals, suggesting a possible increase in the production of
activin from these follicles. It is unlikely that this PB staining represents inhibin B as
a subunit is not detectable in these follicles (Chapter 5).
Levels of pB subunit in the theca cells were maximal in medium and large antral
follicles in animals homozygous for the Fee8 gene. Increased diffusion of PB subunit
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containing proteins may reflect an increase in the production of activin by these
follicles.
Although elevated FSH levels have been reported in animals carrying the FecB gene
(McNatty and Henderson, 1987), further studies have observed no difference in the
secretion of gonadotropins (Souza, et al., 1997b). This may suggest that an increase
in activin may amplify the effect of FSH within the FecB ovary, rather than
concentrations of the gonadotrophin being affected.
To conclude, we have noted an apparent decline in the expression of both a and
(3A subunit protein in the granulosa cells of medium sized antral follicles in animals
homozygous for the Fee8 gene compared to non-carrier ewes. This may reflect a
decrease in the output of inhibin A from each individual follicle, however, the levels
of inhibin secreted into the periphery do not vary between FF and ++ animals
(Souza, et al., 1997b) suggesting that this possible decline in production may be of
local significance within the ovary. It is unlikely, however, that a fall in inhibin A
release by these follicles could be responsible for the phenotype of the Booroola
animals, as there is considerable evidence supporting the hypothesis that the Fee8
mutation results in alterations in the BMP signalling pathway (Mulsant, et al., 2001;
Souza, et al., 2001; Wilson, et al., 2001), which in turn result in a premature induction
of follicle cell differentiation. Therefore, it is likely that the decline in a and (3A
subunit expression in these follicles is a consequence of the mutation and not a cause.
Additionally, the higher levels of (3B subunit expression noted in the medium
sized and large antral follicles ofBooroola animals are also likely to be a result of the
presence of the Fee8 gene. It should be noted that if the [3B subunit staining observed
represents activin, there may be increased responsiveness of these follicles to FSH as
activin has been shown to up-regulate FSH receptor expression and enhance cellular
responsiveness to FSH (Xiao, et al., 1992). Therefore, although the apparent increase
in (3B subunit diffusion from certain follicles in Booroola animals may not be a direct






































EAPRE LAPRE EANT MEDANT LANT
Figure 6.1 Granulosa cell expression of inhibin subunits in both carrier and non-
carriers of the FecB gene. * - P = <0.05; ** - P = <0.001.
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Figure 6.2 Theca cell expression of inhibin subunit protein in carriers and non-







Figure 6.3 Inhibin a, (5A and |3B subunit protein expression in medium antral
follicles in animals with (b, d, f) and without (a, c, e) the FecB gene. TE - Theca
externa; TI - Theca interna; G - Granulosa; AN - Antrum. x400 magnification. Scale
bar represents 100pm.
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Chapter 7 - Activin subunit expression in ovine and murine testes
7.1 Introduction
In a number of mammalian species including the human (Groome, et al., 1996)
and the rat (Lanuza, et al., 1999) the ovary produces both inhibin A and inhibin B,
while the testis only produces the inhibin B dimer (Illingworth, et al., 1996b;
Woodruff et al., 1996).
The detection of inhibin subunit mRNAs and proteins in the ovaries of these
species indicate the production of all three subunits in the granulosa cells. The factors
which modulate the synthesis and binding of inhibin subunits to form the biopotent
dimers remain unknown, however, the research presented in Chapters 4 and 5 of this
thesis may suggest that expression and binding of the subunits is dependent on the
stage of follicle development.
The ovine ovary expresses mRNAs and proteins for a, PA and PB inhibin
subunits, as in the human and the rat; however, in the sheep only inhibin A seems to
be produced with no inhibin B detectable in the circulation. FSH secretion by
cultured ovine pituitary cells is considerably less suppressed by inhibin B than
inhibin A (Robertson, et al., 1997), suggesting that inhibin A and B may have
differing biological roles.
The ram is also unique compared to males of other species studied, as although
all three inhibin subunits are synthesized, inhibin A is found in the circulation with
inhibin B undetectable in peripheral plasma (McNeilly, et al., 2000), mirroring the
situation in the ewe.
Taken together these data suggest the likely preferential dimerisation of inhibin
subunits in the sheep and possibly in the gonads of other species. This hypothesis is
constructed due to the fact that all three subunits are available but a subunit only
binds PA subunit and not PB subunit.
The aim of this study was to examine the expression of inhibin p-subunit
proteins in the testes of two species producing only one form of dimeric inhibin in
order to detect any differences in the pattern of expression throughout the tissue.
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Inhibin a-subunit was assumed to be present in both species as production of any
inhibin form would not be possible without its presence.
7.2 Materials and Methods
Materials
7.2.1 Animal Tissue
Adult ram and rat testes sections were obtained from an in-house histological
archive of fully mature animals. These sections were prepared from testes originally
fixed for an appropriate length of time in 4% PFA and embedded in paraffin blocks.
7.2.2 Primary antibodies
Mouse monoclonal antibodies raised against amino acids 82-114 of the (3A
subunit of human inhibin (E4 clone) and amino acids 82-114 of the human (3B




Sections of 5pm were cut from paraffin blocks containing testicular tissue; the
wax was then removed from the sections using xylene and rehydrated in an ethanol
gradient. The sections were incubated in a 70% methanol: 30% hydrogen peroxide
solution for 30 minutes (to block any endogenous peroxidase activity) prior to a 1
hour incubation with a 20% non-specific serum in PBS blocking solution. Sections
were then incubated with primary antibodies, targeted against the inhibin subunits,
for one hour, washed with PBS and incubated for a further hour with the
corresponding fluorescent second antibody (Sigma). The slides were mounted with
50pl Citifluor (Citifluor. Ltd, London) and the staining visualised using a Zeiss 510
Laser scanning confocal microscope.
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7.3 Results
Immunohistochemistry was used to detect the expression of inhibin (3-subunit
proteins in the mature testes of two species, the sheep and the rat, in an attempt to
identify any differential expression of the subunits in animals producing solely
inhibin A (ram: McNeilly et al, 2000) or inhibin B (male rat; Woodruff, et al., 1996).
In the testis of the rat, staining for [IB subunit protein was observed in the
seminiferous tubules (Figure 7.1), with Sertoli cells, spermatogonium, spermatocytes
and spermatids all staining positively. Only non-specific (3A staining was seen in the
interstitial fluid and the Leydig cells, but no (3A staining was detected in the tubules.
In contrast, staining for both PA and PB subunits was evident in the seminiferous
tubules of the ram.
7.4 Discussion
In the testes sections examined there was a significant difference in the
expression of inhibin subunit protein between the two species studied. In the ram
both pA and pB subunits were detected in the seminiferous tubules, whereas the
tubules of the rat were only positively stained for PB subunit. This observation is
consistent with those made by other groups showing that the adult ram produces
only inhibin A (McNeilly, et al., 2000) and no measurable inhibin B, and that mature
male rats only synthesize inhibin B in their testes (Woodruff, et al., 1996).
The coupling of the PA subunit to the a-subunit of inhibin may be
preferential over the binding of PB to the common a-subunit, at least in the species
studied in this research. Thus in a cell-type which produces all three subunit
proteins, inhibin A would be the mature form synthesised and secreted into the
circulation, as detected in the peripheral plasma of the ram.
However, if the pA subunit was not expressed along with the other two
proteins, the PB subunit would be free to couple to the a-subunit, producing inhibin
B, as observed in the male rat.
Although this hypothesis is consistent for both sexes in the sheep, and in the
male rat, female humans and rats produce both forms of inhibin and therefore express
all three subunits in their ovaries. Therefore, in these animals it seems unlikely that
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there is preferential binding between the p subunits and the common a subunit, and
instead it is likely that the production of the two forms of inhibin is modulated by
additional factors.
These factors may include the relative quantities of the subunits which are
available with specific ratios required for the dimerisation of the different inhibin and
activin forms. This theory is supported by previous research which suggests that at
least eight times more alpha subunit than pA subunit is required for the dimerisation
of inhibin A (Mason et al., 1986). The fact that all three inhibin subunits are
produced by the granulosa cells of the ewe and inhibin B does not seem to be
synthesised, suggests the possibility that the ovine a and PB subunits can not bind
to each other. One strategy which could be employed to investigate this enigma
would be the transfection of a stable cell line with the genes encoding each of the
ovine inhibin subunits. In this way cells could be cultured producing different
combinations of the three subunits, including the synthesis of a and PB in the
absence of pA. This research may indicate whether inhibin B could be produced in
the ewe if PA subunit were not omnipresent in ovine follicles.
There is an additional hypothesis which may explain the preferred production
of one form of inhibin over another if all three subunits are available. If the
production of a form of one activin is preferred to another, for instance in a particular
species activin B is formed in preference to activin A, this would reduce the level of
free PB subunit for inhibin B production.
In summary, the work described in this chapter along with Western blot
detection of inhibin subunits in the sheep ovary (Chapter 5), suggests that the
dimerisation of inhibin subunits in the sheep may well be preferential, with pA
binding to a-subunit even in the presence of the PB subunit. The results of this
study are therefore in agreement with recent reports that the ewe does not produce
inhibin B and that although the ram produces only inhibin A, all three subunits are
present in the testes as they are in the granulosa cells of the ewe. Furthermore, this
work suggests that in the male rat the production of inhibin B may only be possible
in the absence of pA subunit, as in these animals the PA subunit is absent and inhibin
B is produced.
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To conclude, the expression of inhibin subunit proteins and the production of
inhibin forms varies considerably between both species, and gender (Table 7.1).
There are a number of animals, including both sexes of the sheep, which express all
three of the subunits required for the production of both inhibin A and inhibin B,
however, only one form of inhibin is produced. It is therefore likely that in these
animals there is preferential dimerisation of the subunits in order to produce a single
inhibin dimer form.
Measurements of those inhibin forms present in the plasma and subunits
expressed in the gonads of additional species may well shed more light on the
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Table 7.1 Inhibin subunit expression and inhibin forms detected in the gonads and
plasma of various species.
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Figure 7.1 Inhibin pA-subunit (c, d) and pB-subunit staining (e, f) in the testes of
the adult ram, and rat. (a) and (b) are control tissue sections. ST - Seminiferous
tubule; LC - Leydig Cell; IF - Interstitial fluid. Scale bar represents 100pm.
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Chapter 8 - General Discussion
Prior to the start of the work contained in this thesis, evidence of the
involvement of inhibins and activins in the process of folliculogenesis had been
widely reported. It was known that at the level of the pituitary inhibin had the ability
to suppress the release of FSH (Keogh, et al., 1976) with locally produced activin
having the opposite effect and stimulating the secretion of the gonadotrophin from
the same cells (Ling, et al., 1986). A significant amount of work had also been carried
out examining the local effects of inhibins and activins within the ovary with both
hormones identified as modulators of steroidogenesis (Miro, et al., 1991; Wrathall
and Knight, 1995) and potentiators of gonadotrophic action within the ovary (Xiao,
etal., 1992; Findlay, 1993).
Furthermore, the development of specific two-site enzyme-linked
immunosorbent assays for inhibin A and inhibin B allowed the measurement of the
individual dimers in biological fluids for the first time (Groome, et al., 1994;
Robertson, et al., 1997). However, the majority of this work was carried out in the
rat and the human, with levels of the two forms of inhibin and the ovarian origin of
the hormones unidentified in the sheep.
Therefore, the objectives of the work presented in this thesis were as follows:
• The identification of the source of dimeric inhibins in the ovine ovary.
• The examination of the expression of inhibin subunits throughout the
ovine oestrous cycle.
• An investigation into the inhibin and activin forms produced by the
ovine ovary.
• The definition of any differences seen in inhibin subunit expression in
sheep with a high ovulation rate.
8.1 Follicular production of inhibin and activin in the ewe
Measurement of inhibin A in the jugular and ovarian veins confirmed that the
ovary produces the majority of inhibin A detectable in the circulation of the ewe
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(Chapter 3). This is in agreement with previous research identifying the ovary as the
main origin of total inhibin in the sheep (Mann, et al., 1989). The levels of inhibin A
measured in the follicular fluids of the follicles collected for the study and in the
media collected during in vitro incubation of these follicles, indicated that large
oestrogenic follicles produce and release the greatest quantity of the hormone in
relation to other follicle classes. Furthermore, it was noted that both large
nonoestrogenic follicles and small antral follicles also synthesize and release a
significant amount of the protein. These observations show that large oestrogenic
follicles produce large quantities of inhibin A and oestradiol. These two hormones
both inhibit FSH secretion by the pituitary, and therefore large oestrogenic follicles
have the capability to reduce circulating levels of FSH and thus suppress the growth
of subordinate follicles within the ovary. However, examination of the levels of
inhibin A and FSH concentrations in peripheral blood, indicates that the fall in FSH
seen in the early follicular phase is not due to an increase in circulating inhibin A.
This suppression of FSH during the early follicular phase is therefore likely to be
caused by the increase in oestradiol secretion from the ovary at this time. As the fall
in peripheral FSH levels during the follicular phase is essential for the selection of
ovulatory follicles, these observations implicate oestradiol as the primary regulator of
follicle selection through the modulation of plasma FSH levels. If this is the case,
suppression of FSH secretion by ovary-derived inhibin A may well be of more
significance at other stages in the cycle, such as during the luteal phase when
pituitary LH release, and hence ovarian oestradiol secretion, is depressed.
The fact that large follicles produce more inhibin than small follicles was
supported by the immunohistochemical staining for inhibin subunits in the ovaries of
the sheep (Chapter 4). The expression of a subunit was limited to the granulosa cells
of those follicles classified as late preantral or antral follicles. However, as previous
research has suggested that an 8-fold excess of a subunit over (3A subunit is
necessary for the production of inhibin A (Mason et al., 1986) it is unlikely that
preantral follicles produce inhibin as expression of the a subunit is minimal compared
to that seen for both [3 subunits. In addition, the levels of (3A subunit increased with
follicle size with the staining most intense in large antral follicles.
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Detection of inhibin A throughout the cycle revealed a number of differences
between the relative contributions of the follicles size classes at the various points
studied (Chapter 3). Perhaps the most significant alterations in the production and
output of both inhibin A and oestradiol occurred during the early follicular phase of
the cycle. Measurement of FSH in the periphery reached a nadir during this time-
point reflecting the increase in negative feedback to the pituitary by oestradiol and
inhibin A at this time. As expected, oestradiol secretion by large follicles reached a
peak at this stage of the cycle. However, inhibin A release by large follicles was
comparable with those levels detected during the mid-luteal stage of the cycle from
the same follicle class. This is further evidence to support the previous hypothesis
that oestradiol is the principal cause of the fall in FSH characteristic of the early
follicular phase in ewes. This decline in the concentration of FSH seems to have an
adverse effect on the level of inhibin A secretion by both small antral and large
oestrogenic follicles, indicating that inhibin A release by these follicles is reliant upon
FSH while oestradiol release from large oestrogenic follicles is more dependant on
LH.
In contrast to the differences observed in the release of inhibin A throughout
the ovine oestrous cycle, the expression of the subunit proteins did not vary
significantly from one stage of the cycle to the next (Chapter 4). This is, in some
ways, unsurprising as there was no variation seen in the level of inhibin A present in
the follicular fluids of the follicles studied during the cycle, suggesting that production
of the subunit proteins remains fairly constant despite changes in gonadotrophin
concentrations in the blood.
The presence of inhibin (3 subunit in the theca cell layers of late preantral and
early antral follicles is almost certainly due to the diffusion of the proteins through
the cell layers from the granulosa cells and not production of the subunits by the
theca cells, as mRNAs for inhibin subunits were only ever recorded in the granulosa
compartment of follicles. This ability of (3 subunits, as activin dimers, has been noted
previously, with the molecule able to travel up to 7 cell lengths through embryonic
Xenopus tissue, via rapid diffusion and the establishment of an activin gradient across
the tissue. The fact that [3 subunit protein was detected in small preantral follicles,
with undetectable mRNA for the subunits, has been reported previously (McNatty,
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et al., 2000) as well as being observed in this work. We propose that the most likely
source of (3 subunit staining in small preantral follicles is activin, which has diffused
from the granulosa cells of larger antral follicles.
Research has shown that activin stimulates the growth of preantral mouse
follicles from immature animals, while maintaining an inhibitory effect on preantral
follicles in adult mice (Yokota, et al., 1997). Furthermore, additional studies have
provided evidence that activin secreted by secondary follicles causes preantral mouse
follicles from adult mice, cultured in vitro, to remain quiescent in the resting stage of
growth (Mizunuma, et al., 1999).
Therefore, if the [IB subunit staining seen in the theca cells represents activin,
it is possible that it is able to diffuse through the theca cell layers of large follicles,
and for some distance through the stromal tissue of the ovary, to exert a likely
negative effect on the growth of neighbouring preantral follicles. In addition, the
intense staining for (3B subunit proteins seen in the zona pellucida may implicate
activin B in signalling between the cumulus granulosa cells and the oocyte.
It is possible that diffusion of activin from antral follicles may play a
significant role in the precocious development of ovulatory follicles in Fee8 ewes. As
documented in Chapter 6 of this thesis, the diffusion of (3B subunit protein through
the theca cell layers is significantly greater from larger antral follicles in animals
carrying the Fee8 gene. Although activin has been shown to exert a negative effect on
preantral follicles in mice, the dimer has the ability to enhance the effect of FSH on
the maturation of granulosa cells within the ovary (Xiao, et al., 1992). However, as
recent research has suggested that the Booroola phenotype is caused by an alteration
in BMP signalling pathways (Mulsant, et al., 2001; Souza, et al., 2001), it is likely
that alterations in inhibin subunit expression are a result of this disruption to a
pathway involved in the induction of cellular differentiation.
8.2 Molecular forms of inhibin in the sheep
The work presented in Chapters 3 and 4 of this thesis employed antibodies
targeted against regions of the mature a, (3A and (3B inhibin subunits. However, as
well as identifying proteins containing the mature subunit forms, these antibodies will
also bind to precursor forms which are also present in the ovaries of the ewe.
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The fact that the immunoassay utilised in Chapter 3 uses a sandwich technique
with two antibodies used to specifically detect mature inhibin dimers, allowed the
detection of dimerised inhibin A. However, to investigate the forms of inhibin
subunits identified with immunostaining in Chapter 4, and also to detect possible
inhibin B dimers, a Western blotting protocol was employed.
The absence of inhibin B dimers in the follicular fluid of ovine follicles is in
agreement with recent research which, using a validated specific assay, was unable to
detect inhibin B in the blood of the male or female sheep (McNeilly, 2000).
Thus, although the granulosa cells of antral follicles may synthesize inhibin B
as well as inhibin A, it is unlikely that it is secreted into the bloodstream or follicular
fluid.
Inhibin B has been identified as the major inhibin form in the human male and
the male rat, and has also been shown to play a significant role in folliculogenesis in
the females of these species, which both produce inhibin A in addition to inhibin B.
The fact that inhibin B is not present in the plasma of the ewe or ram prompts the
question, why is inhibin B not required in the sheep, if it plays a significant role in
other species?
Inhibin B has less activity than inhibin A in suppressing FSH secretion by
ovine pituitary cells (Robertson, et al., 1997); therefore the primary role of inhibin B
in the sheep may be as a paracrine/autocrine factor within the ovary rather than as a
'true' hormone.
Further research centred around the role of inhibin B in those species in which
it is found may offer an explanation for its absence in the sheep.
Furthermore, the detection of a, (3A and pB subunits in the same gonadal
cells in both male and female sheep, would suggest that the production of both
inhibin A and B should occur as observed in the female human and rat (Groome, et
al., 1996; Lanuza, et al., 1999).
As all three subunit proteins are present in the ovine ovary and testis, why is
iiiliibiii B not secreted in either sex? One possible explanation is that inhibin A is
produced preferentially in these animals.
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There are a number of possible theories as to why this selective production of
inhibin A might occur in the sheep. The binding of a subunit to the PB subunit may
not be physically possible due to slight differences in the amino acid sequences of the
two subunits, which may prevent the formation of inhibin but do not interrupt the
dimerisation of the subunits to form activin. It is also possible that the affinity of pB
subunits for each other is stronger in the sheep than their affinity for a subunits, so
that as pB subunits are produced, activin is formed, leaving little pB subunit free in
the granulosa to produce inhibin. It is also important to note that in the rat testis
there is no inhibin A produced due to a lack of pA subunit expression, and in the rat
ovary inhibin A is only produced when pA subunit is expressed late in
folliculogenesis. These observations provide additional evidence for the hypothesis
that preferential dimerisation of inhibin subunits exists in these species.
8.3 General conclusions
The work described in this thesis shows that large oestrogenic follicles are the
major source of inhibin A in the ewe, with both small antral and large non-oestrogenie
follicles contributing significant amounts. Furthermore, the secretion of inhibin A by
small antral and large oestrogenic follicles falls during the early follicular phase,
concomitant with a decline in peripheral FSH. Oestradiol secretion by large
oestrogenic follicles remains unaffected by the fall in FSFI demonstrating the
dependence of inhibin A release on FSH, while oestradiol secretion is able to transfer
its stimulus from FSH to LH.
In addition, we suggest that inhibin P subunits, possibly in the form of activin,
are able to diffuse through the ovine ovary, exerting an effect on the growth and
differentiation of neighbouring follicles. This diffusion is enhanced in the ovaries of
ewes with an increased ovulation rate and may offer an explanation for the early
maturation of ovulatory follicles in these animals.
Finally, in contrast to females from other species, we have shown that it is
unlikely that the ewe secretes inhibin B into the circulation, and that the binding of
subunits during the formation of inhibins and activins in the sheep and a number of
other species may well be preferential.
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These conclusions are summarised in Figure 8.1, which shows the interactions
between inhibin and activin produced by certain ovarian follicles and their effects on
FSH secretion (endocrine) and action (autocrine/paracrine), and their hypothesised
effects on adjacent follicles within the ovary.
Primordial Large Preantral Antral Follicle
Follicles Follicle
Figure 8.1 Summary diagram showing the involvement of inhibins and activins in the
process of follicle development in the sheep.
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Set up tubes as above, the primary antibody used (AB) is a sheep anti-oestradiol
antibody (BW 26/9/82) diluted in PGel (assay buffer) to relevant tubes (working
dilution is 1:500,000).
Add lOOul of the 125I E2 tracer (10,000-12,000cpm/100(il) diluted in PGel. Leave the
tubes overnight at 4°C.
Day 2
Add second antibody, 125|il SAGS (sheep anti-goat serum) diluted 1:20 in PGel and
125|il normal sheep serum (1:200 in PGel). Leave the tubes overnight at 4°C.
Day 3
Add 250ul of PGel containing 1% Tween 20 to all tubes except TCs and NSBs, spin
at 3000rpm for 30 minutes at 4°C. Drain supernatant and count pellets on gamma




Standard/QC Buffer Sample Medium AB
Total Counts - - - - -
NSBs - 200pl - 50pl -
BOs - lOOpl - 50(il lOOpl
Standards lOOpl - - 50(0,1 lOOpl
QCs 50pl lOOpl - - lOOpl
Samples - lOOjlll 50pl - lOOpl
Set up tubes as above, primary antibody (AB) used is anti-androstenedione RB3 at a
final working dilution of 1:3,000,000.
Add lOOul of the 125I A4 tracer (10,000-12,OOOcpm/lOOpl) diluted in PGel. Leave the
tubes overnight at 4°C.
Day 2
Add second antibody, 125|0,1 SAGS (sheep anti-goat serum) diluted 1:20 in PGel and
125|oi normal sheep serum (1:200 in PGel). Leave the tubes overnight at 4°C.
Day 3
Add 250ul of PGel containing 1% Tween 20 to all tubes except TCs and NSBs, spin
at 3000rpm for 30 minutes at 4°C. Drain supernatant and count pellets on gamma




standards/QC Buffer Sample Ovx plasma AB
total counts - - - - -
NSB's - 200 pi - 50 pi -
BO's - 100 pi - 50 pi 100 pi
standards 100 pi - - 50 pi 100 pi
QC's 50 pi 100 pi - - 100 pi
sample - 100 pi 50 pi - 100 pi
Set up tubes as above. Primary antibody (AB) used is lyophilized antiserum (SAPU
S235-201) with a working dilution of 1:30,000.
Add 100 jxl of 125I P4 tracer (approximately 15,000 cpm), diluted in Phosphate
Citrate Buffer (PCB) with 10 mg/10 ml ANSA (8-Anilino-l Napthaline Sulphonic
Acid) and without gelatin, to all tubes. Mix tubes and incubate for at least three hours
at room temperature.
Add 100|Ltl DARS and 1 OOjj.1 NRS to all tubes (except total counts), mix the tubes
and leave overnight at 4°C.
Day 2
Add 1ml 0.9% saline to all tubes (except total counts), spin 3000 rpm for 30 minutes









Gelatin (not in tracer buffer)
17.85 g 35.70 g
7.75 g 15.5 g
0.1 g 0.2 g





standards/QC Buffer Sample AB
Total counts - - - -
NSB's - 350 |il
BO's - 300 nl - 50 pi
Standards 150 pi - - 50 pi
QC's 150 pi 150 pi - 50 pi
Sample - 150 pi 150 pi 50 pi
Set up tubes as described above, the primary antibody used is NIDDK-NIH anti-
ovine FSH-1 used at a working dilution of 1:12000.
Day 2
Add 50pl 125I labeled NIAMMD oFSH-19 to all tubes in the assay (approximately
15,000 cpm/tube), mix and incubate at 4oC overnight.
Day 3
Add 100 pi donkey anti-rabbit serum (DARS; SAPU), diluted 1:32 in assay buffer,
and 100 ml normal rabbit serum (NRS; SAPU), diluted 1:400 in assay buffer to all
tubes (except the total counts). Mix the tubes and incubate overnight at 4oC.
Day 4
Add 1ml 0.9% Saline, 4% PEG, 0.2% Triton X to all tubes except the total counts.
Spin for 25 minutes at 3000rpm, 4oC. Decant the supernatant, allow tubes to dry




Add 100)0,1 of standards/QCs/samples/blanks to an eppendorf tube. Add 50|il of 6%
SDS solution. Boil tubes at 100°C for 3 minutes. Cool and add 50|ll of freshly
prepared 6% hydrogen peroxide followed by 100(0,1 of assay buffer. Incubate at room
temperature for 30 minutes.
E4 coated plates? Add 80|ol of sample/standard/QC per well to an E4 precoated
plate in duplicate. Incubate at room temperature overnight. Plates should be covered
with a plate sealer and placed in a sealed box with damp paper towels.
Day 2
Discard plate contents and wash x20 with wash buffer. Make a 1/1000 dilution of
PPG biotinylated antibody in assay buffer containing 1% (v/v) mouse serum and add
50(0,1 to each well. Incubate at room temperature for 3 hours. Wash x20 with wash
buffer. Make a 1/1000 dilution of streptavidin alkaline phosphatase in assay buffer
containing and add 50(0,1 to each well. Incubate at room temperature for 1 hour. Wash
x20 with wash buffer. Add 50|ol of alkaline phosphatase substrate per well.
Incubate at room temperature for 2 hours. Add 50|ol of amplifier. Wait until the OD
of the top standard is between 1-1-5 then stop with 50(0.1 of 0-4M HC1. Read at

















Distilled water 1 litre





0.5M Stock phosphate buffer 200 ml
Distilled water 1800 ml
149
FSH Assay Buffer









0.5M Phosphate Buffer 750 ml
Distilled water 4250 ml
1% BSA/PBS /Store at 4oC)
g/litre
Bovine serum albumin 10
0.075M PBS 1000 ml
150
Inhibin A Buffers
Amido black solution (0 06% w/v)
Dissolve 60mg of amido black in 100ml of deionised water.





Dissolve in 80ml deionised water and adjust pH to 7-5 with HC1. Add 01 g of
sodium azide and 2ml of 0-06% amido black. Make up to 100ml with further
deionised water.
Hydrogen peroxide






Dissolve in about 300ml deionised water. Adjust pH to 7-5 with HC1 then make up







• Dewax sections in xylene for 5 mins.
• Rehydrate sections using alcohol gradient.
• Boil in citrate buffer for 5 minutes.
• Wash slides 2 x 5 minutes in PBS.
• Block in blocking solution for 30 minutes.
• Make up primary antibody/antibodies in blocking solution. For double
fluorescent staining the antibodies must be from different species.
• Add antibody to slides (approx 50|al/slide).
• Incubate overnight at 4°C
Day 2
• Wash slides 2 x 5mins in PBS
• Incubate slides with second antibodies raised against the primary antibody
species (one FITC, one TRITC conjugate), diluted to 1:50 in blocking
solution, for 1 hour.
• Wash 2x5 minutes in PBS.
• Add 50(il Citifluor (Glycerol/PBS solution) to each slide.
• Add a coverslip and use mounting adhesive to seal the edges.
• Visualise on a confocal microcope.
Buffers
Phosphate buffered saline (PBS)
Sigma Tablets 1 per 200mls dH20
Blocking Solution




• Sample homogenised (tissue) in 1 ml protein extraction buffer.
• Diluted to 1:10 in extraction buffer
• Protein concentration measured x3 using Genequant
• Dilution of original extract calculated to give 2|ig/pl
• 20|ll of sample mixed with 5pl of sample application buffer and loaded onto
4-20% Tris-Glycine precast gel
• Gel run at 120V, 26ma for 2 hours
• Gel removed from cassette and placed into sandwich with PVDF membrane
and whatman paper
• Transferred in blotting module at 30V, 400ma for 2 hours
• Membrane blocked with Porcine serum (5% in TBS-T) for 1 hour
• Washed 3x 10 minutes with TBS-T
• Incubated at room temperature with primary antibody (1:1000) with 5%
porcine serum in TBS-T for one hour
• Washed x3 TBS-T
• Incubated at room temperature with alkaline phosphatase linked secondary
antibody (1:20000) with 5% porcine serum
• Washed x3 TBS-T
• Membrane laid flat in square petri dish, 2ml ECF substrateadded evenly to
surface left in dark at room temperature for 20 minutes
• Gel stained Coomassie solution for five minutes and destained for -30
minutes
• Membrane lifted and rested on whatman paper and dried in dark at room
temperature for 20 minutes






Protease Inhibitor (1 tablet - Boehringer Mannheim)
TBS-T (1L)
50 ml 1M Tris HC1



























0.5% w/v Coomassie Brilliant Blue
30% Methanol









Reaction Mix Full Reaction Half Reaction
5X Transcription Buffer 4|il 2(il
lOOmM DTT 2(il l(ll
rRNasin 20 units (1(0.1) 0.5pl
rNTPs 4(il 2(0,1
Linearised Plasmid DNA lfol 0.5(il
35S UTP lOOpCi 50(iCi
Polymerase (T3 or T7) lpl 0.5|il
DEPC H20 to 20|ol lOpl
Incubate the above mixture for 1 hour at 37oC then add the following:
Full Reaction Half Reaction
DEPC H20 10(0,1 20(0,1
tRNA (lOmg/ml) 10(0,1 10(0,1
5X Transcription Buffer 8(0.1 8|ol
rRNasin l|ll 1 (0.1
ROl RNase-free Dnase LpJ l(ll
Final Volume 50(0,1 50pl




1) Dewax in histoclear 2x10 mins
2) 100% Ethanol 2x2 mins
3) 95 - 80 - 60 - 30% Ethanol 2 mins each
4) 0.85% NaCl 5 mins
5) IX Phosphate Buffered Saline (PBS) 5 mins
6) 4% Paraformaldehyde (PFA) in PBS 20 mins
7) IX PBS 2x5 mins
8) Proteinase K (lmg/ml) 7.5 mins
400mls: 40ml0.1MEDTA
40 ml 1M Tris
320 ml DEPC
800ml Proteinase K
9) IX PBS 5 mins
10) 4% PFA in PBS 5 mins
11)DEPCH20 10 sees
12) 2X SSC 2 mins
13) 0.1M Triethanolamine-HCL and 10 mins
Acetic anhydride
14) 2X SSC 2 mins
15) 60 - 80 - 95 - 100% Ethanol 2 mins each
16) Chloroform 5 mins
17) 100% Ethanol 2 mins
18) 95% Ethanol 2 mins

















2) Wash slides thoroughly in 2X SSC at 55°C.
3) RNaseA (20mg/ml) in 2X SSC at 37°C
4) 2X SSC, 0.1% P-mercaptoethanol
5) IX SSC, 0.1% P-mercaptoethanol
6) IX SSC, 0.1% P-mercaptoethanol, 50% formamide
7) 0.1X SSC, 0.1% p-mercaptoethanol
8) 60 - 80 - 95 - 100% Ethanol
9) Dry slides in fumehood.
10) Expose, develop and fix as described in Chapter 2.
60 mins
15 mins
15 mins
15 mins
2x15 mins
2 mins each
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